<SEC-DOCUMENT>0001079973-25-001213.txt : 20250801
<SEC-HEADER>0001079973-25-001213.hdr.sgml : 20250801
<ACCEPTANCE-DATETIME>20250801163028
ACCESSION NUMBER:		0001079973-25-001213
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250730
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250801
DATE AS OF CHANGE:		20250801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DUOS TECHNOLOGIES GROUP, INC.
		CENTRAL INDEX KEY:			0001396536
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				650493217
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39227
		FILM NUMBER:		251176612

	BUSINESS ADDRESS:	
		STREET 1:		7660 CENTURION PARKWAY
		STREET 2:		SUITE 100
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32256
		BUSINESS PHONE:		904-296-2807

	MAIL ADDRESS:	
		STREET 1:		7660 CENTURION PARKWAY
		STREET 2:		SUITE 100
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32256

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DUOS TECHNOLOGY GROUP, INC.
		DATE OF NAME CHANGE:	20150710

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFORMATION SYSTEMS ASSOCIATES, INC.
		DATE OF NAME CHANGE:	20070416
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>duot_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:DUOT="http://duostech.com/20250730">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_DUOT_duostech.com_20250730 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250730_20250730 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001396536 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000004" name="dei:EntityCentralIndexKey">0001396536</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="duot-20250730.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001396536</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-30</xbrli:startDate>
        <xbrli:endDate>2025-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>



<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.25pc solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_902_edei--DocumentType_c20250730__20250730_zzEtcws75o8g"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_900_edei--DocumentPeriodEndDate_c20250730__20250730_z7uKi4eU4oE1"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 30, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20250730__20250730_zWIgiF9bhUx"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000011" name="dei:EntityRegistrantName">Duos Technologies Group, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in its
charter)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; text-align: center"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20250730__20250730_zj7aAv6slSob"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Florida</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_90E_edei--EntityFileNumber_c20250730__20250730_zkJLkiUP40jl"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000013" name="dei:EntityFileNumber">001-39227</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20250730__20250730_zV3qFe1MyXL1"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000014" name="dei:EntityTaxIdentificationNumber">65-0493217</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 8pt"><i>(State or Other Jurisdiction</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>(Commission</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>(I.R.S. Employer</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 8pt"><i>of Incorporation)</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>File Number)</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>Identification No.)</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250730__20250730_ziay7c5JzYCk"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000015" name="dei:EntityAddressAddressLine1">7660 Centurion Parkway</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20250730__20250730_zscqNNDK4o11"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20250730__20250730_zlMkmUiBYsS1"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000017" name="dei:EntityAddressCityOrTown">Jacksonville</ix:nonNumeric></span>,
<span id="xdx_90B_edei--EntityAddressStateOrProvince_c20250730__20250730_zP9W20e7cCYl"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20250730__20250730_zklcYwFLnuy1"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000019" name="dei:EntityAddressPostalZipCode">32256</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of Principal Executive Offices) (Zip
Code)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--CityAreaCode_c20250730__20250730_zd7aQZvxP0H4"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000020" name="dei:CityAreaCode">(904)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20250730__20250730_zcUGEvgYzEE2"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000021" name="dei:LocalPhoneNumber">296-2807</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Registrant&#8217;s telephone number, including
area code)</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90A_edei--WrittenCommunications_c20250730__20250730_zSHOgiz39fe7"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_905_edei--SolicitingMaterial_c20250730__20250730_zk0HhprIVWt2"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20250730__20250730_znBuFNNdQYki"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20250730__20250730_znfMmmtaH2I5"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_904_edei--Security12bTitle_c20250730__20250730_ztsiWPodoLna"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000026" name="dei:Security12bTitle">Common Stock (par value $0.001 per share)</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_edei--TradingSymbol_c20250730__20250730_zSRvRcrMiXSc"><ix:nonNumeric contextRef="AsOf2025-07-30" id="Fact000027" name="dei:TradingSymbol">DUOT</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20250730__20250730_zYNIpIZYyWS1"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20250730__20250730_zkfGMrWcrgX5"><ix:nonNumeric contextRef="AsOf2025-07-30" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.25pc solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 1.01 Entry Into a Material Definitive Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>	</b>On July 30, 2025, Duos Technologies
Group, Inc. (the &#8220;Company&#8221;) priced its recently announced public offering (the &#8220;Offering&#8221;) of common stock,
par value $0.001 per share (the &#8220;Common Stock&#8221;), for gross proceeds of approximately $36.9 million. The securities in
the Offering were offered and sold by the Company pursuant to an effective shelf registration statement on Form S-3, which was
initially filed with the Securities and Exchange Commission  on June 12, 2023 and, as amended, was declared effective on June 21, 2023 (File No. 333-272603),  and the Registration Statement on Form S-3MEF, filed on July 30. 2025
(File No. 333-289106), and the base prospectus dated June 21, 2023, as supplemented by the
preliminary prospectus supplement filed on July 30, 2025 and a final prospectus supplement filed on August 1, 2025 (the
&#8220;Prospectus Supplement&#8221;) pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;). The Offering closed on August 1, 2025. 	</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">The
Offering was conducted pursuant to an underwriting agreement (the &#8220;Agreement&#8221;) between the Company and Titan Partners Group
LLC, a division of American Capital Partners, LLC, as the sole bookrunner (the &#8220;Underwriter&#8221;), that was entered into on July
30, 2025. Pursuant to the Agreement, we sold 6,666,667 shares of Common Stock
in the Offering at a public offering price of $6.00 per share, less underwriting discounts and commissions.
We also granted the Underwriter a 30-day option to purchase up to an additional 838,851 shares of Common Stock  from
the Company at the public offering price, less underwriting discounts and commissions. We also agreed to issue to the Underwriter a warrant
to purchase 333,334 shares of Common Stock.
The underwriter&#8217;s warrant is exercisable immediately and for a period of five years from the date of the Agreement, at an exercise
price of $7.20 per share. The material terms of the Offering are described in the Registration Statement and the Prospectus Supplement.
The Agreement contains customary representations, warranties and agreements of us. We also agreed in the Agreement to indemnify the Underwriter
against certain liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">The
foregoing descriptions of the Agreement  and underwriter warrant are not complete and are qualified in their entirely
by reference to the full text of the Agreement and a form of underwriter warrant, copies of which are filed
as Exhibits 1.1 and  4.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">The
legal opinion and consent of Shutts &amp; Bowen LLP relating to the securities is filed as Exhibit 5.1 to this Current Report on Form
8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">On
July 30, 2025, the Company issued two press releases, the first announcing that it had commenced the Offering and the second announcing
the pricing of the Offering. Copies of these press releases are filed as Exhibits 99.1 and 99.2, respectively, to this Current Report
on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 9.01 Financial Statements and Exhibits. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 62px"><span style="font-size: 8pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: top; width: 10px">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 8pt"><b>Description of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1x1.htm">Underwriting Agreement, dated July 30, 2025, between Duos Technologies Group, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC.</a></span></p></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4x1.htm">Form of Underwriter Warrant</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5x1.htm">Opinion of Shutts &amp; Bowen LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5x1.htm">Consent of Shutts &amp; Bowen LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99x1.htm">Press Release, dated July 30, 2025, regarding commencement of the Offering.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99x2.htm">Press Release, dated July 30, 2025, regarding pricing of the Offering.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">Cover Page Interactive Data File
    (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pc">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>DUOS TECHNOLOGIES GROUP, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 55%">&#160;</td>
    <td style="width: 6%">&#160;</td>
    <td style="width: 39%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Dated: August 1, 2025</td>
    <td>By:&#160;&#160;</td>
    <td style="border-bottom: Black 1pt solid">/s/&#160;<i>Adrian G. Goldfarb</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td rowspan="2">
    Adrian G. Goldfarb<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1x1.htm
<DESCRIPTION>UNDERWRITING AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 1.1</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Duos
Technologies Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6,666,667
SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
WARRANTS TO PURCHASE 0 SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Underwriting
Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
30, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
Partners Group LLC,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of American Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Representative of the several Underwriters listed in <U>Schedule A</U> hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
Titan Partners Group LLC,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of American Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
World Trade Center, 29th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10007</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duos
Technologies Group, Inc., a Florida corporation (the &ldquo;<U>Company</U>&rdquo;), confirms its agreement with Titan Partners Group
LLC, a division of American Capital Partners, LLC (&ldquo;<U>Titan Partners</U>&rdquo;), and each of the other Underwriters named in
<U>Schedule&nbsp;A</U> hereto (collectively, the &ldquo;<U>Underwriters</U>,&rdquo; which term shall also include any underwriter substituted
as hereinafter provided in Section&nbsp; 10 hereof), for which Titan Partners is acting as representative (in such capacity, the &ldquo;<U>Representative</U>&rdquo;),
with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective
numbers of (a) shares of common stock, par value $0.001 per share, of the Company (&ldquo;<U>Common Stock</U>&rdquo;), as set forth in
Schedule A hereto, and (b) pre-funded warrants to purchase up to the number of shares of the Common Stock, as set forth in Schedule A
hereto (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;), at an exercise price set forth in Schedule A hereto; and (ii) the grant by the
Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any
part of 838,851 additional shares of Common Stock. The aforesaid 6,666,667 shares of Common Stock (the &ldquo;<U>Closing Shares</U>&rdquo;)
and the Pre-Funded Warrants to be purchased by the Underwriters, as well as all or any part of the 838,851 shares of Common Stock subject
to the option described in Section 2(b) hereof (the &ldquo;<U>Option Shares</U>&rdquo;), are herein collectively referred to as the &ldquo;<U>Securities</U>.&rdquo;
The shares of the Company&rsquo;s Common Stock issuable upon exercise of the Pre-Funded Warrants are herein referred to as the &ldquo;<U>Warrant
Shares</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company understands that the Underwriters propose to make a public offering of the Securities as soon as the Representative deems advisable
after this Underwriting Agreement (this &ldquo;<U>Agreement</U>&rdquo;) has been executed and delivered. The terms of the Pre-Funded
Warrants are set forth in the form of the Pre-Funded Warrant attached hereto as Exhibit B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) a shelf registration statement on
Form&nbsp;S-3 (No. 333-272603) and Form S-3MEF (333-289106), covering the public offering and sale of certain securities, including the
Securities, under the Securities Act of 1933, as amended (the &ldquo;<U>1933 Act</U>&rdquo;) and the rules and regulations of the Commission
promulgated thereunder (the &ldquo;<U>1933 Act Regulations</U>&rdquo;), which shelf registration statement was declared effective on
June 21, 2023. Such registration statement, as of any time, means such registration statement as amended by any post-effective amendments
thereto to such time, including the exhibits and any schedules thereto at such time, the documents incorporated or deemed to be incorporated
by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and the documents otherwise deemed to be a part
thereof as of such time pursuant to Rule 430B under the 1933 Act Regulations (&ldquo;<U>Rule 430B</U>&rdquo;), and is referred to herein
as the &ldquo;Registration Statement;&rdquo; provided, however, that the &ldquo;Registration Statement&rdquo; without reference to a
time means such registration statement as amended by any post-effective amendments thereto as of the time of the first contract of sale
for the Securities, which time shall be considered the &ldquo;new effective date&rdquo; of such registration statement with respect to
the Securities within the meaning of paragraph (f)(2) of Rule 430B, including the exhibits and schedules thereto as of such time, the
documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and
the documents otherwise deemed to be a part thereof as of such time pursuant to the Rule 430B. Any registration statement filed pursuant
to Rule 462(b) of the 1933 Act Regulations in connection with the offer and sale of the Securities is herein called the &ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; and, after such filing, the term &ldquo;Registration Statement&rdquo; shall include the Rule
462(b) Registration Statement. Each preliminary prospectus supplement used in connection with the offering of the Securities, including
the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, are
collectively referred to herein as a &ldquo;preliminary prospectus.&rdquo; Promptly after execution and delivery of this Agreement, the
Company will prepare and file a final prospectus supplement relating to the Securities in accordance with the provisions of Rule 424(b)
under the 1933 Act Regulations (&ldquo;Rule 424(b)&rdquo;). The final prospectus supplement, in the form first furnished or made available
to the Underwriters for use in connection with the offering of the Securities, including the documents incorporated or deemed to be incorporated
by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, are collectively referred to herein as the &ldquo;Prospectus.&rdquo;
For purposes of this Agreement, all references to the Registration Statement, any preliminary prospectus, the Prospectus or any amendment
or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering,
Analysis and Retrieval system (or any successor system) (&ldquo;<U>EDGAR</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Time</U>&rdquo; means 8:30 P.M. New York City time, on July 30, 2025 or such other time as agreed by the Company and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>General
Disclosure Package</U>&rdquo; means any Issuer General Use Free Writing Prospectuses issued at or prior to the Applicable Time, the most
recent preliminary prospectus (including any documents incorporated therein by reference) that is distributed to investors prior to the
Applicable Time and the information included on <U>Schedule&nbsp;B-1</U> hereto, all considered together.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Free Writing Prospectus</U>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the 1933 Act Regulations
(&ldquo;<U>Rule 433</U>&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the
1933 Act Regulations (&ldquo;<U>Rule 405</U>&rdquo;)) relating to the Securities that is (i) required to be filed with the Commission
by the Company, (ii) a &ldquo;road show for an offering that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i),
whether or not required to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i)
because it contains a description of the Securities or of the offering that does not reflect the final terms, in each case in the form
filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s records
pursuant to Rule 433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
General Use Free Writing Prospectus</U>&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to
prospective investors (other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433 (a &ldquo;<U>Bona Fide
Electronic Road Show</U>&rdquo;)), as evidenced by its being specified in <U>Schedule&nbsp;B-2</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Limited Use Free Writing Prospectus</U>&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Testing-the-Waters
Communication</U>&rdquo; means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the
1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Written
Testing-the-Waters Communication</U>&rdquo; means any Testing-the-Waters Communication that is a written communication within the meaning
of Rule 405 under the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references in this Agreement to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included&rdquo;
or &ldquo;stated&rdquo; (or other references of like import) in the Registration Statement, any preliminary prospectus or the Prospectus
shall be deemed to include all such financial statements and schedules and other information incorporated or deemed incorporated by reference
in the Registration Statement, any preliminary prospectus or the Prospectus, as the case may be, prior to the execution and delivery
of this Agreement; and all references in this Agreement to amendments or supplements to the Registration Statement, any preliminary prospectus
or the Prospectus shall be deemed to include the filing of any document under the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder (collectively, the &ldquo;<U>1934 Act</U>&rdquo;), incorporated or deemed to be incorporated
by reference in the Registration Statement, such preliminary prospectus or the Prospectus, as the case may be, at or after the execution
and delivery of this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 1.</FONT> <U>Representations and Warranties by the Company</U>. The Company represents
and warrants to each Underwriter as of the date hereof, the Applicable Time, the Closing Time (as defined below) and any Date of Delivery
(as defined below), and agrees with each Underwriter, as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Registration Statement and Prospectuses</U>. The Company meets the requirements for use of Form S-3 under the 1933 Act. Each of the
Registration Statement and any amendment thereto has become effective under the 1933 Act, including General Instruction I.B.1 of Form
S-3. The aggregate market value of the outstanding voting and non-voting common equity (as defined in 1933 Act Rule 405) of the Company
held by persons other than affiliates of the Company (pursuant to 1933 Act Rule 144, those that directly, or indirectly through one or
more intermediaries, control, or are controlled by, or are under common control with, the Company) (the &ldquo;<U>Non-Affiliate Shares</U>&rdquo;),
was equal to more than $75 million (calculated by multiplying (x) the highest price at which the common equity of the Company closed
on Nasdaq within 60 days of the date of this Agreement times (y) the number of Non-Affiliate Shares). The Company is not a shell company
(as defined in Rule 405 under the 1933 Act) and has not been a shell company for at least 12 calendar months previously and if it has
been a shell company at any time previously, has filed current Form 10 information (as defined in Instruction I.B.6 of Form S-3) with
the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company. No stop order suspending
the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued by the Commission under the 1933
Act, no order preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued by the Commission and
no proceedings for any of those purposes have been instituted by the Commission or are pending or, to the Company&rsquo;s knowledge,
contemplated by the Commission. The Company has complied with each request (if any) from the Commission for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Registration Statement and any post-effective amendment thereto, at the time of its effectiveness and at each deemed effective
date with respect to the Underwriters pursuant to Rule 430B(f)(2) under the 1933 Act Regulations, complied in all material respects with
the requirements of the 1933 Act and the 1933 Act Regulations. Each preliminary prospectus, the Prospectus and any amendment or supplement
thereto, at the time each was filed with the Commission, complied in all material respects with the requirements of the 1933 Act and
the 1933 Act Regulations. Each preliminary prospectus delivered to the Underwriters for use in connection with the offering and the Prospectus
was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the
extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, when they became effective
or at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements
of the 1934 Act and the rules and regulations of the Commission under the 1934 Act (the &ldquo;<U>1934&nbsp;Act&nbsp;Regulations</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registration Statement, any preliminary prospectus and the Prospectus, and the filing of the Registration Statement, any preliminary
prospectus and the Prospectus with the Commission have been duly authorized by and on behalf of the Company, and the Registration Statement
has been duly executed pursuant to such authorization.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Accurate Disclosure</U>. Neither the Registration Statement nor any amendment thereto, at its effective time, at the Closing Time
or at any Date of Delivery, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading. As of the Applicable
Time, none of (A) the General Disclosure Package, (B) any individual Issuer Limited Use Free Writing Prospectus, when considered together
with the General Disclosure Package, nor (C) any individual Written Testing-the-Waters Communication, when considered together with the
General Disclosure Package, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date,
at the time of any filing with the Commission pursuant to Rule 424(b), at the Closing Time or at any Date of Delivery, included, includes
or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading. The documents incorporated
or deemed to be incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, at the time
the Registration Statement became effective or when such documents incorporated by reference were filed with the Commission, as the case
may be, when read together with the other information in the Registration Statement, the General Disclosure Package or the Prospectus,
as the case may be, did not and will not include an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement (or any
amendment thereto), the General Disclosure Package or the Prospectus (or any amendment or supplement thereto, including any prospectus
wrapper) made in reliance upon and in conformity with written information furnished to the Company by any Underwriter through the Representative
expressly for use therein. For purposes of this Agreement, the only information so furnished shall be the information in the first paragraph
under the caption &ldquo;Discounts, Commissions and Expenses,&rdquo; the statements under the caption &ldquo;Price Stabilization, Short
Positions and Penalty Bids&rdquo; and the statements related specifically to the underwriter under the caption &ldquo;Electronic Distribution&rdquo;
in each case contained under the caption &ldquo;Underwriting&rdquo; in each case contained in the Prospectus (collectively, the &ldquo;<U>Underwriter
Information</U>&rdquo;).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>
<U>Issuer Free Writing Prospectuses</U>. No Issuer Free Writing Prospectus conflicts or will conflict with the information contained
in the Registration Statement or the Prospectus, including any document incorporated by reference therein, and any preliminary or other
prospectus deemed to be a part thereof that has not been superseded or modified. No filing of any &ldquo;road show&rdquo; (as defined
in Rule 433(h)) is required in connection with the offering of the Securities. Any Issuer Free Writing Prospectus that the Company is
required to file pursuant to Rule 433(d) under the 1933 Act has been, or will be, filed with the Commission in accordance with the requirements
of the 1933 Act and the 1933 Act Regulations. Each Issuer Free Writing Prospectus that the Company has filed, or is required to file,
pursuant to Rule 433(d) under the 1933 Act or that was prepared by or on behalf of or used or referred to by the Company complies or
will comply in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations. Except for the Issuer Free Writing
Prospectuses, if any, identified in <U>Schedule B-2</U> hereto, and electronic road shows, if any, each furnished to the Representative
before first use, the Company has not prepared, used or referred to, and will not, without the prior consent of the Representative, prepare,
use or refer to, any issuer free writing prospectus. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>
<U>Testing-the-Waters Materials</U>. The Company (A) has not engaged in any Testing-the-Waters Communication other than Testing-the-Waters
Communications with the consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule
144A under the 1933 Act or institutions that are accredited investors within the meaning of Rule 501 under the 1933 Act and (B) has not
authorized anyone other than the Representative to engage in Testing-the-Waters Communications. The Company reconfirms that the Representative
has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT>
<U>Company Not Ineligible Issuer</U>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the
earliest time thereafter that the Company or another offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2)
of the 1933 Act Regulations) of the Securities and at the date hereof, the Company was not and is not an &ldquo;ineligible issuer,&rdquo;
as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that
the Company be considered an ineligible issuer.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT>
<U>[Intentionally omitted]</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT>
<U>Independent Accountants</U>. Salberg &amp; Company, P.A., the accounting firm that certified the financial statements and supporting
schedules of the Company that are incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus,
is an independent registered public accounting firm as required by the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act
Regulations and the Public Company Accounting Oversight Board (United States).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT>
<U>SEC Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the 1933 Act and the 1934 Act, including pursuant to Section 13(a) or 15(d) thereof, for the twelve months preceding the date hereof
(or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the
exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively
referred to herein as the &ldquo;SEC Reports&rdquo;) on a timely basis or has received a valid extension of such time of filing and has
filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all
material respects with the requirements of the 1933 Act and the 1934 Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer
subject to Rule 144(i) under the 1933 Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT>
<U>Financial Statements; Non-GAAP Financial Measures</U>. The financial statements (including the related notes thereto) of the Company
included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, together with
the related schedules and notes, comply as to form in all material respects with Regulation S-X under the 1933 Act and present fairly,
in all material respects, the financial position of the Company and its consolidated Subsidiaries (as defined below) at the dates indicated
and the statement of operations, stockholders&rsquo; equity and cash flows of the Company and its consolidated Subsidiaries for the periods
specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&ldquo;<U>GAAP</U>&rdquo;)
applied on a consistent basis throughout the periods covered thereby, except in the case of unaudited interim financial statements, which
are subject to normal year-end adjustments and do not contain certain footnotes as permitted by the applicable rules of the Commission,
and any supporting schedules, if any, present fairly, in all material respects, the information required to be stated therein. The selected
financial data and the summary financial information, if any, and other financial data included or incorporated by reference in the Registration
Statement, the General Disclosure Package and the Prospectus has been derived from the accounting records of the Company and present
fairly, in all material respects, the information shown therein and have been compiled on a basis consistent with that of the audited
financial statements included therein. Except as included therein, no historical or pro forma financial statements or supporting schedules
are required to be included or incorporated by reference in the Registration Statement, the General Disclosure Package or the Prospectus
under the 1933 Act or the 1933 Act Regulations. All disclosures contained in the Registration Statement, the General Disclosure Package
or the Prospectus, or incorporated by reference therein, regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined
by the rules and regulations of the Commission) comply with Regulation G of the 1934 Act, and Item 10 of Regulation S-K, to the extent
applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration
Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and
has been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT>
<U>Compliance with the Sarbanes-Oxley Act of 2002</U>. There is and has been no failure on the part of the Company or any of the Company&rsquo;s
directors or officers, in their capacities as such, to comply in all material respects with any applicable provision of the Sarbanes-Oxley
Act of 2002 and the rules and regulations promulgated in connection therewith, with which the Company is required to comply, including
Section 402 related to loans.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT>
<U>No Material Adverse Change in Business</U>. Except as otherwise stated therein, since the respective dates as of which information
is given in the Registration Statement, the General Disclosure Package or the Prospectus, (i) there has not been any change in the capital
stock (other than the issuance of shares of Common Stock upon exercise of stock options and warrants described as outstanding in, and
the grant of options and awards under the Company&rsquo;s existing stock-based compensation plans (the &ldquo;<U>Company Stock Plans</U>&rdquo;)
described in, and the issuance of any stock upon the conversion of Company securities described in the Registration Statement, the General
Disclosure Package and the Prospectus, and the repurchase or retirement of shares of capital stock pursuant to agreements providing for
an option to repurchase or a right of first refusal on behalf of the Company pursuant to the Company&rsquo;s repurchase rights), any
change in short-term debt or long-term debt of the Company, or any dividend or distribution of any kind declared, set aside for payment,
paid or made by the Company on any class of capital stock, or any material adverse change, or any development that would reasonably be
expected to result in a material adverse change, in or affecting the business, properties, management, financial position, stockholders&rsquo;
equity, results of operations or prospects of the Company, whether or not arising in the ordinary course of business (a &ldquo;<U>Material
Adverse Effect</U>&rdquo;); (ii) the Company has not entered into any transaction or agreement (whether or not in the ordinary course
of business) that is material to the Company or incurred any liability or obligation, direct or contingent, that is material to the Company;
(iii) the Company has not sustained any loss or interference with its business that is material to the Company and that is either from
fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action,
order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the
Registration Statement, the General Disclosure Package and the Prospectus; and (iv) there has been no dividend or distribution of any
kind declared, paid or made by the Company on any class of its capital stock.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT>
<U>Litigation</U>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of
the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court,
arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, a
&ldquo;<U>Legal Action</U>&rdquo;) which (i) adversely affects or challenges the legality, validity or enforceability of this Agreement
or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse
Effect. Neither the Company nor any Subsidiary, nor, to the Company&rsquo;s knowledge, any director or officer thereof, is or has been
the subject of any Legal Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach
of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by
the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop
order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the 1934
Act or the 1933 Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT>
<U>Good Standing of the Company</U>. The Company has been duly organized and is validly existing and its status is active under the laws
of its jurisdiction of organization, is duly qualified to do business and is in good standing in each jurisdiction in which its ownership
or lease of property or the conduct of its business requires such qualification, and has all power and authority necessary to own or
hold its properties and to conduct the business in which it is engaged, except where the failure to be so qualified or in good standing
or have such power or authority would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
Other than as disclosed in Exhibit 21.1 of the Company&rsquo;s most recent Annual Report on Form 10-K, the Company does not have any
direct or indirect subsidiaries and does not own or control, directly or indirectly, any corporation, association or other entity.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT>
<U>Good Standing of the Company&rsquo;s Subsidiaries</U>. Each subsidiary of the Company (each, a &ldquo;<U>Subsidiary</U>&rdquo; and,
collectively, the &ldquo;<U>Subsidiaries</U>&rdquo;) has been duly organized and is validly existing and its status is active under the
laws of the jurisdiction of its incorporation or organization, has corporate or similar power and authority to own, lease and operate
its properties and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus
and is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required, whether
by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or to be in
good standing would not result in a Material Adverse Effect. Except as otherwise disclosed in the Registration Statement, the General
Disclosure Package and the Prospectus, all of the issued and outstanding capital stock of each Subsidiary has been duly authorized and
validly issued, is fully paid and non-assessable and is owned by the Company, directly or through Subsidiaries, free and clear of any
security interest, mortgage, pledge, lien, encumbrance, claim or equity. None of the outstanding shares of capital stock of any Subsidiary
was issued in violation of the preemptive or similar rights of any securityholder of such Subsidiary. The only Subsidiaries of the Company
are the entities listed on Exhibit 21 to the Registration Statement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT>
<U>Capitalization</U>. The authorized, issued and outstanding shares of capital stock of the Company are as set forth in the Registration
Statement, the General Disclosure Package and the Prospectus in the column entitled &ldquo;Actual&rdquo; under the caption &ldquo;Capitalization&rdquo;
(except for subsequent issuances, if any, (A) pursuant to this Agreement, (B) pursuant to reservations, agreements or employee benefit
plans referred to in the Registration Statement, the General Disclosure Package and the Prospectus or (C) pursuant to the conversion
of convertible securities or exercise of options referred to in the Registration Statement, the General Disclosure Package and the Prospectus).
The outstanding shares of capital stock of the Company have been duly authorized and are validly issued, fully paid and non-assessable.
None of the outstanding shares of capital stock of the Company was issued in violation of the preemptive or other similar rights of any
securityholder of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT>
<U>Stock Options</U>. Except where the failure to do so would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect, with respect to the stock options (the &ldquo;<U>Stock Options</U>&rdquo;) granted pursuant to the Company Stock
Plans, (i) each Stock Option intended to qualify as an &ldquo;incentive stock option&rdquo; under Section 422 of the Internal Revenue
Code of 1986, as amended, and the regulations and published interpretations thereunder (the &ldquo;<U>Code</U>&rdquo;), so qualifies,
(ii) each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms
to be effective (the &ldquo;<U>Grant Date</U>&rdquo;) by all necessary corporate action, including, as applicable, approval by the board
of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary
number of votes or written consents, and, to the knowledge of the Company (other than with respect to the execution and delivery by the
Company) the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant
was made, in all material respects, in accordance with the terms of the Company Stock Plans, the 1934 Act and all other applicable laws
and regulatory rules or requirements, including the rules of Nasdaq Capital Market and any other exchange on which Company securities
are traded, and (iv) each such grant was properly accounted for in accordance with GAAP in the financial statements (including the related
notes) of the Company. Each Company Stock Plan is accurately described in all material respects in the Registration Statement, the General
Disclosure Package and the Prospectus. The Company has not knowingly granted, and there is no and has been no policy or practice of the
Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with, the release or other public announcement
of material information regarding the Company or its results of operations or prospects.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT>
<U>Authorization of Agreement; Authorization of Pre-Funded Warrants.</U> This Agreement has been duly authorized, executed and delivered
by the Company. The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement
and the Pre-Funded Warrants will not contravene any provision of (i) applicable law, (ii) the certificate of incorporation or by-laws
of the Company, (iii) any agreement or other instrument binding upon the Company or any of its Subsidiaries that is material to the Company
and its Subsidiaries, taken as a whole, or (iv) any judgment, order or decree of any governmental body, agency or court having jurisdiction
over the Company or any Subsidiary, except that, in the case of clause (i) and (iii) as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect on the Company or on the power and ability of the Company to perform its obligations
under this Agreement or, the Pre-Funded Warrants, and no consent, approval, authorization or order of, or qualification with, any governmental
body, agency or court is required for the performance by the Company of its obligations under this Agreement or, the Pre-Funded Warrants,
except such as may be required by the securities or Blue Sky laws of the various states in connection with the offer and sale of the
Securities or as provided in Section 1(y).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT>
<U>Authorization and Description of Securities</U>. The Shares to be purchased by the Underwriters from the Company have been duly authorized
for issuance and sale to the Underwriters pursuant to this Agreement and, when issued and delivered by the Company pursuant to this Agreement
against payment of the consideration set forth herein, will be validly issued and fully paid and non-assessable; and the issuance of
the Shares is not subject to the preemptive or other similar rights of any securityholder of the Company. The Common Stock conforms to
all statements relating thereto contained in this Agreement, including Exhibit B hereto, the Registration Statement, the General Disclosure
Package and the Prospectus and such description conforms to the rights set forth in the instruments defining the same. No holder of Shares
will be subject to personal liability by reason of being such a holder. The Pre-Funded Warrants have been duly authorized and, when executed
and delivered by the Company in accordance with this Agreement, will be valid and legally binding agreements of the Company, enforceable
against the Company in accordance with their terms except as the enforcement thereof may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable
principles. The maximum number of Warrant Shares to be issued by the Company upon exercise of the Pre-Funded Warrants in accordance therewith
have been duly authorized and have been or will be reserved for issuance upon exercise of the Pre-Funded Warrants in a number sufficient
to meet the current exercise requirements. The Warrant Shares, when issued and delivered upon exercise of the Pre-Funded Warrants in
accordance therewith, will be validly issued, fully paid and non-assessable, and the issuance of the Warrant Shares is not subject to
any preemptive or similar rights not otherwise validly waived or satisfied.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT>
<U>Registration Rights</U>. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, to
the extent that any person has the right to require the Company to register any securities for sale under the 1934 Act by reason of the
filing of the Registration Statement with the Commission or the issuance and sale of the Securities, those rights have been waived as
of the date of this Agreement with respect to such filing or issuance and sale of Securities pursuant to this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT>
<U>Absence of Violations, Defaults and Conflicts</U>. Neither the Company nor any Subsidiary is (A) in violation of its charter, by-laws
or similar organizational document, (B) in default in the performance or observance of any obligation, agreement, covenant or condition
contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument
to which the Company or any Subsidiary is a party or by which either of them may be bound or to which any of the properties or assets
of the Company or any Subsidiary is subject (collectively, &ldquo;<U>Agreements and Instruments</U>&rdquo;), except for such defaults
that would not, individually or in the aggregate, result in a Material Adverse Effect, or (C) in violation of any law, statute, rule,
regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other
authority, body or agency having jurisdiction over the Company or its Subsidiaries or any of their respective properties, assets or operations
(each, a &ldquo;<U>Governmental Entity</U>&rdquo;), except for such violations that would not, individually or in the aggregate, result
in a Material Adverse Effect. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
herein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Securities,
the execution and delivery of the Warrants and the use of the proceeds from the sale of the Securities as described therein under the
caption &ldquo;<U>Use of Proceeds</U>&rdquo;) and compliance by the Company with its obligations hereunder have been duly authorized
by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict
with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any
lien, charge or encumbrance upon any properties or assets of the Company or its Subsidiaries pursuant to, the Agreements and Instruments
(except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, individually or
in the aggregate, result in a Material Adverse Effect), nor will such action result in any violation of the provisions of the charter,
by-laws or similar organizational document of the Company or its Subsidiaries or any law, statute, rule, regulation, judgment, order,
writ or decree of any Governmental Entity. As used herein, a &ldquo;<U>Repayment Event</U>&rdquo; means any event or condition which
gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&rsquo;s behalf) the right
to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT>
<U>Listing</U>. The Closing Shares, Option Shares and Warrant Shares have been approved for listing on the NASDAQ Capital Market, subject
to notice of issuance.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT>
<U>Absence of Labor Dispute</U>. No labor dispute with the employees of the Company or its Subsidiaries exists or, to the knowledge of
the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or
its Subsidiaries&rsquo; principal suppliers, manufacturers, customers or contractors, which, in either case, would result in a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT>
<U>Absence of Proceedings</U>. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus,
there is no action, suit, proceeding, inquiry or investigation before or brought by any Governmental Entity (including, without limitation,
the Department of Energy, Department of Homeland Security, the Transportation Security Administration or the Federal Railroad Administration),
or any comparable regulatory authority in any jurisdiction now pending or, to the knowledge of the Company, threatened, against or affecting
the Company or its Subsidiaries, which would reasonably be expected to result in a Material Adverse Effect, or which would reasonably
be expected to materially and adversely affect their respective properties or assets or the consummation of the transactions contemplated
in this Agreement or the performance by the Company of its obligations hereunder; and the aggregate of all pending legal or governmental
proceedings to which the Company or any such Subsidiary is a party or of which any of their respective properties or assets is the subject
which are not described in the Registration Statement, the General Disclosure Package and the Prospectus, including ordinary routine
litigation incidental to the business, would not reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT>
<U>Accuracy of Exhibits</U>. There are no contracts or documents which are required to be described in the Registration Statement, the
General Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement which have not been so described
and filed as required.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT>
<U>No Consents Required</U>. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree
of, any Governmental Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with
the offering, issuance or sale of the Securities hereunder or the consummation of the transactions contemplated by this Agreement, except
such as have been already obtained or as may be required under the 1933 Act, the 1933 Act Regulations, the rules of the Nasdaq Stock
Market LLC, state securities laws or the rules of the Financial Industry Regulatory Authority, Inc. (&ldquo;<U>FINRA</U>&rdquo;).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT>
<U>Possession of Licenses and Permits</U>. The Company and its Subsidiaries possess such permits, licenses, approvals, consents and other
authorizations (collectively, &ldquo;<U>Governmental Licenses</U>&rdquo;) issued by the appropriate Governmental Entities necessary to
conduct the business now operated by them (including, without limitation, all such permits, licenses, approvals, consents and other authorizations
required by local, State and Federal Governmental Entities to build and operate data centers and otherwise as may be required by the
Department of Energy, Department of Homeland Security, the Transportation Security Administration or the Federal Railroad Administration
for the operation of the business now operated by the Company and its Subsidiaries), except where the failure so to possess would not,
individually or in the aggregate, result in a Material Adverse Effect. The Company and its Subsidiaries are in compliance with the terms
and conditions of all Governmental Licenses, except where the failure so to comply would not, individually or in the aggregate, result
in a Material Adverse Effect. The Company has fulfilled and performed all of its material obligations with respect to the Governmental
Licenses and, to the knowledge of the Company, no event has occurred which allows, or after notice or lapse of time would allow, revocation
or termination thereof or results in any other material impairment of the rights of the Company as a holder of any permit, except where
the failure to so fulfill or perform, or the occurrence of such event, would not, individually or in the aggregate, result in a Material
Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except where the invalidity of such Governmental
Licenses or the failure of such Governmental Licenses to be in full force and effect would not, individually or in the aggregate, result
in a Material Adverse Effect. Neither the Company nor its Subsidiaries has received any notice of proceedings relating to the revocation
or modification of any Governmental Licenses which, individually or in the aggregate, if the subject of an unfavorable decision, ruling
or finding, would result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT>
<U>Title to Property</U>. The Company and its Subsidiaries have good and marketable title to all real property owned by them and good
title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests, claims,
restrictions or encumbrances of any kind except such as (A) are described in the Registration Statement, the General Disclosure Package
and the Prospectus or (B) do not, individually or in the aggregate, materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company or its Subsidiaries; and all of the leases and subleases
material to the business of the Company and its Subsidiaries, considered as one enterprise, and under which the Company or its Subsidiaries
holds properties described in the Registration Statement, the General Disclosure Package or the Prospectus, are in full force and effect,
and neither the Company nor any such Subsidiary has any notice of any material claim of any sort that has been asserted by anyone adverse
to the rights of the Company or any Subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the
rights of the Company or such Subsidiary to the continued possession of the leased or subleased premises under any such lease or sublease.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT>
<U>Title to Intellectual Property</U>. The Company owns or has valid, binding and enforceable licenses or other rights under the patents,
patent applications, licenses, inventions, copyrights, know how (including trade secrets and other unpatented and/or unpatentable proprietary
or confidential information, systems or procedures), trademarks, service marks, trade names or other intellectual property necessary
for, or used in the conduct, or the proposed conduct, of the business of the Company in the manner described in the Registration Statement,
the General Disclosure Package and the Prospectus (collectively, the &ldquo;<U>Intellectual Property</U>&rdquo;) and to the extent that
the Company has not obtained and recorded assignments confirming its ownership rights, it will obtain confirmatory assignments by no
later than August 31, 2025; the patents, trademarks, and copyrights, if any, included within the Intellectual Property are valid, enforceable,
and subsisting; other than as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, (A) the Company
is not obligated to pay a material royalty, grant a license to, or provide other material consideration to any third party in connection
with the Intellectual Property, (B) the Company has not received any notice of any claim of infringement, misappropriation or conflict
with any asserted rights of others with respect to any of the Company&rsquo;s drug candidates, services, processes or Intellectual Property,
(C) to the knowledge of the Company, neither the sale nor use of any of the discoveries, inventions, drug candidates, services or processes
of the Company referred to in the Registration Statement, the General Disclosure Package or the Prospectus do or will, to the knowledge
of the Company, infringe, misappropriate or violate any right or valid patent claim of any third party, (D) none of the technology employed
by the Company has been obtained or is being used by the Company in material violation of any contractual obligation binding on the Company
or, to the Company&rsquo;s knowledge, upon any of its officers, directors or employees or otherwise in violation of the rights of any
persons, (E) to the knowledge of the Company, no third party has any ownership right in or to any Intellectual Property that is owned
by the Company, other than any co-owner of any patent constituting Intellectual Property who is listed on the records of the U.S. Patent
and Trademark Office (the &ldquo;<U>USPTO</U>&rdquo;) and any co-owner of any patent application constituting Intellectual Property who
is named in such patent application until the Company obtains and records assignments from any such co-owner named in an application
or patent, assigning to the Company all ownership rights, and, to the knowledge of the Company, no other third party has any ownership
right in or to any Intellectual Property in any field of use that is exclusively licensed to the Company, other than any licensor to
the Company of such Intellectual Property, (F) there is no material infringement by third parties of any Intellectual Property, (G) there
is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others challenging the Company&rsquo;s
rights in or to any Intellectual Property, and (H) there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit,
proceeding or claim by others challenging the validity or scope of any Intellectual Property. The Company is in compliance in all material
respects with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company, and all such agreements
are in full force and effect. For the avoidance of doubt, the Company owns all Intellectual Property necessary for, or used in the conduct,
or the proposed conduct, of the Company&rsquo;s Duos Edge AI Inc. and Duos Energy Corporation business.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT>
<U>Patents and Patent Applications</U>. All patents and patent applications owned by or licensed to the Company or under which the Company
has rights have, to the knowledge of the Company, been duly and properly filed and maintained, including timely payment of all maintenance
and renewal fees; to the knowledge of the Company, the parties prosecuting such patent applications have complied with their duty of
candor and disclosure to the USPTO in connection with such applications; and the Company is not aware of any facts required to be disclosed
to the USPTO that were not disclosed to the USPTO and which would preclude the grant of a patent in connection with any such application
or would reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect
to such applications. To the Company&rsquo;s knowledge, all patents and patent applications owned by the Company and filed with the USPTO
or any foreign or international patent authority (the &ldquo;<U>Company Patent Rights</U>&rdquo;) and all patents and patent applications
in-licensed by the Company and filed with the USPTO or any foreign or international patent authority (the &ldquo;<U>In-licensed Patent
Rights</U>&rdquo;) have been duly and properly filed; the Company believes it has complied with its duty of candor and disclosure to
the USPTO for the Company Patent Rights and, to the Company&rsquo;s knowledge, the licensors of the In-licensed Patent Rights have complied
with their duty of candor and disclosure to the USPTO for the In-licensed Patent Rights.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT>
<U>[Intentionally omitted]</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT>
<U>[Intentionally omitted]</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT>
[<U>Intentionally omitted]</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT>
<U>Environmental Laws</U>. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus or would
not, individually or in the aggregate, result in a Material Adverse Effect, (A) neither the Company nor any Subsidiary is in violation
of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial
or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution
or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface
or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release
of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing
materials or mold (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) or to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of Hazardous Materials (collectively, &ldquo;<U>Environmental Laws</U>&rdquo;), (B) the Company
and its Subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in
compliance with their requirements, (C) there are no pending or, to the knowledge of the Company threatened, administrative, regulatory
or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings
relating to any Environmental Law against the Company or any Subsidiary and (D) to the Company&rsquo;s knowledge, there are no events
or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding
by any private party or Governmental Entity, against or affecting the Company or any Subsidiary relating to Hazardous Materials or any
Environmental Laws.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT>
<U>Accounting Controls and Disclosure Controls</U>. The Company and each of its Subsidiaries maintain effective internal control over
financial reporting (as defined under Rule 13-a15 and 15d-15 under the rules and regulations of the Commission under the 1934 Act Regulations
and a system of internal accounting controls sufficient to provide reasonable assurances that (A)&nbsp;transactions are executed in accordance
with management&rsquo;s general or specific authorization; (B)&nbsp;transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain accountability for assets; (C) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization; (D) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences; and (E) the interactive data in eXtensible Business
Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly
presents the information called for in all material respects and is prepared in accordance with the Commission&rsquo;s rules and guidelines
applicable thereto. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, since the end
of the Company&rsquo;s most recent audited fiscal year, there has been (1) no material weakness in the Company&rsquo;s internal control
over financial reporting (whether or not remediated) and (2) no change in the Company&rsquo;s internal control over financial reporting
that has materially adversely affected, or is reasonably likely to materially adversely affect, the Company&rsquo;s internal control
over financial reporting. The Company and each of its Subsidiaries maintain an effective system of disclosure controls and procedures
(as defined in Rule 13a-15 and Rule 15d-15 under the 1934 Act Regulations) that are designed to ensure that information required to be
disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission&rsquo;s rules and forms, and is accumulated and communicated to the Company&rsquo;s
management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow
timely decisions regarding disclosure.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT>
<U>Payment of Taxes</U>. All material United States federal income tax returns of the Company and its Subsidiaries required by law to
be filed have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except
assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided in conformity
with GAAP. The United States federal income tax returns of the Company through the fiscal year ended December 31, 2023 have been settled
and no assessment in connection therewith has been made against the Company. The Company and its Subsidiaries have filed all other tax
returns that are required to have been filed by them pursuant to applicable foreign, state, local or other law except insofar as the
failure to file such returns would not result in a Material Adverse Effect, and have paid all taxes due pursuant to such returns or pursuant
to any assessment received by the Company and its Subsidiaries, except for such taxes, if any, as are being contested in good faith and
as to which adequate reserves have been established by the Company. The charges, accruals and reserves on the books of the Company in
respect of any income and corporation tax liability for any years not finally determined are, in conformity with GAAP, adequate to meet
any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacy
that would not result in a Material Adverse Effect. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT>
<U>Insurance</U>. The Company and its Subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable
insurers, in such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or
similar business, and all such insurance is in full force and effect. The Company has no reason to believe that it or its Subsidiaries
will not be able (A)&nbsp;to renew its existing insurance coverage as and when such policies expire or (B)&nbsp;to obtain comparable
coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would
not result in a Material Adverse Effect. Neither of the Company nor its Subsidiaries has been denied any insurance coverage which it
has sought or for which it has applied. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT>
<U>Investment Company Act</U>. The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and
the application of the net proceeds therefrom as described in the Registration Statement, the General Disclosure Package and the Prospectus
will not be required, to register as an &ldquo;investment company&rdquo; under the Investment Company Act of 1940, as amended (the &ldquo;<U>1940&nbsp;Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT>
<U>Absence of Manipulation</U>. Neither the Company nor any affiliate of the Company has taken, nor will the Company or any affiliate
take, directly or indirectly, any action which is designed, or would be expected, to cause or result in, or which constitutes, the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities or to result in a violation
of Regulation M under the 1934 Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(mm)</FONT>
<U>Foreign Corrupt Practices Act</U>. None of the Company, its Subsidiaries or, to the knowledge of the Company, any director, officer,
agent, employee, affiliate or other person acting on behalf of the Company or its Subsidiaries is aware of or has taken any action, directly
or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules
and regulations thereunder (the &ldquo;<U>FCPA</U>&rdquo;), including, without limitation, making use of the mails or any means or instrumentality
of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or
other property, gift, promise to give, or authorization of the giving of anything of value to any &ldquo;foreign official&rdquo; (as
such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in
contravention of the FCPA and the Company has and, to the knowledge of the Company, its affiliates have conducted their businesses in
compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected
to continue to ensure, continued compliance therewith.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT>
<U>Money Laundering Laws</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;<U>Money Laundering
Laws</U>&rdquo;); and no action, suit or proceeding by or before any Governmental Entity involving the Company or its Subsidiaries with
respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT>
<U>OFAC</U>. None of the Company, its Subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate
or representative of the Company or its Subsidiaries is an individual or entity (&ldquo;<U>Person</U>&rdquo;) currently the subject or
target of any sanctions administered or enforced by the United States Government, including, without limitation, the U.S. Department
of the Treasury&rsquo;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, His Majesty&rsquo;s
Treasury, or other relevant sanctions authority (collectively, &ldquo;<U>Sanctions</U>&rdquo;), nor is the Company located, organized
or resident in a country or territory that is the subject of Sanctions; and the Company will not directly or indirectly use the proceeds
of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partners
or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding,
is the subject of Sanctions or in any other manner that will result in a violation by any Person (including any Person participating
in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(pp)</FONT>
<U>Statistical and Market-Related Data</U>. Any statistical and market-related data included in the Registration Statement, the General
Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be
reliable and accurate and, to the extent required, the Company has obtained the written consent to the use of such data from such sources.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qq)</FONT>
<U>Privacy and Data Protection</U>. The Company and its Subsidiaries have operated their business in a manner compliant in all material
respects with all United States federal, state, local and non-United States privacy, data security and data protection laws and regulations
applicable to the Company&rsquo;s collection, use, transfer, protection, disposal, disclosure, handling, storage and analysis of personal
data. The Company and its Subsidiaries have been and are in compliance in all material respects with internal policies and procedures
designed to ensure the integrity and security of the data collected, handled or stored in connection with its business; the Company and
its Subsidiaries have been and are in compliance in all material respects with internal policies and procedures designed to ensure compliance
with the Health Care Laws that govern privacy and data security and take, and have taken reasonably appropriate steps designed to assure
compliance with such policies and procedures. The Company and its Subsidiaries have taken reasonable steps to maintain the confidentiality
of its personally identifiable information, protected health information, consumer information and other confidential information of
the Company, its Subsidiaries and any third parties in its possession (&ldquo;<U>Sensitive Company Data</U>&rdquo;). The tangible or
digital information technology systems (including computers, screens, servers, workstations, routers, hubs, switches, networks, data
communications lines, technical data and hardware), software and telecommunications systems used or held for use by the Company and its
Subsidiaries (the &ldquo;<U>Company&nbsp;IT&nbsp;Assets</U>&rdquo;) are adequate and operational for, in accordance with their documentation
and functional specifications, the business of the Company and its Subsidiaries as now operated and as currently proposed to be conducted
as described in the Registration Statement, the General Disclosure Package and the Prospectus. The Company and its Subsidiaries have
used reasonable efforts to establish, and have established, commercially reasonable disaster recovery and security plans, procedures
and facilities for the business consistent with industry standards and practices in all material respects, including, without limitation,
for the Company IT Assets and data held or used by or for the Company and its Subsidiaries. The Company and its Subsidiaries have not
suffered or incurred any security breaches, compromises or incidents with respect to any Company IT Asset or Sensitive Company Data,
except where such breaches, compromises or incidents would not reasonably be expected to, individually or in the aggregate, result in
a Material Adverse Effect; and there has been no unauthorized or illegal use of or access to any Company IT Asset or Sensitive Company
Data by any unauthorized third party. The Company and its Subsidiaries have not been required to notify any individual of any information
security breach, compromise or incident involving Sensitive Company Data.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(rr)</FONT>
<U>No Broker Fees</U>. Except as disclosed in the General Disclosure Package, there are no contracts, agreements or understandings between
the Company and any person that would give rise to a valid claim against the Company or any Underwriter for a brokerage commission, finder&rsquo;s
fee or other like payment in connection with the offering of the Securities contemplated hereby.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ss)</FONT>
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the General Disclosure Package, none of the officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any
officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other
than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company
and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(tt)</FONT>
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable as a result of the Underwriters and the Company fulfilling their
obligations or exercising their rights under this Agreement, and any other documents or agreements executed in connection with the transactions
contemplated hereunder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(uu)</FONT>
<U>No Integrated Offering</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval
provisions of any trading market or exchange on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vv)</FONT>
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Time, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Time. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ww)</FONT>
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xx)</FONT>
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Code, and the Company shall so certify upon the Representative&rsquo;s request.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(yy)</FONT>
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(zz)</FONT>
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires completed by each of
the Company&rsquo;s directors and officers immediately prior to the offering of the Securities and in the Lock-up Agreements (as defined
below) provided to the Underwriters is true and correct in all respects and the Company has not become aware of any information which
would cause the information disclosed in such questionnaires to become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aaa)</FONT>
<U>FINRA Affiliation</U>. No officer, director or any beneficial owner of 10% or more of the Company&rsquo;s unregistered securities
has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with the rules and regulations
of FINRA) that is participating in the offering of the Securities. The Company will advise the Representative and Underwriters&rsquo;
counsel if it learns that any officer, director or owner of 10% or more of (i) the Company&rsquo;s outstanding shares of Common Stock
or (ii) any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock,
including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible
into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock is or becomes an affiliate
or associated person of a FINRA member firm.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bbb)</FONT>
<U>Board of Directors</U>. The Board of Directors is comprised of the persons set forth in the Company&rsquo;s Definitive Proxy Statement
on Schedule 14A filed with the Commission on April 14, 2025. The qualifications of the persons serving as board members and the overall
composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable to the
Company and the rules of the Nasdaq Stock Market LLC. At least one member of the Board of Directors qualifies as a &ldquo;financial expert&rdquo;
as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Nasdaq Stock Market
LLC. In addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as defined
under the rules of the Nasdaq Stock Market LLC. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ccc)</FONT>
<U>Cybersecurity</U>. (i)(x) There has been no material security breach or other compromise of or relating to any of the Company&rsquo;s
or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its
respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology
(collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has
no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its
IT Systems and Data; (ii) the Company and the Subsidiaries are presently in material compliance with all applicable laws or statutes
and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies
and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and
Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain
and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems
and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry
standards and practices. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ddd)</FONT>
<U>ERISA Compliance</U>. The Company and its Subsidiaries and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee
Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;<U>ERISA</U>&rdquo;))
established or maintained by the Company, its Subsidiaries or their &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance
in all material respects with ERISA. &ldquo;ERISA Affiliate&rdquo; means, with respect to the Company or any of its Subsidiaries, any
member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Code of which the Company or such Subsidiary
is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is reasonably expected to occur with respect
to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates.
No &ldquo;employee benefit plan&rdquo; established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates, if
such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo; (as defined
under ERISA). Neither the Company, its Subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any
liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo; or
(ii) Sections 412, 4971, 4975 or 4980B of the Code. Each employee benefit plan established or maintained by the Company, its Subsidiaries
or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred,
whether by action or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(eee)</FONT>
<U>No Rights to Purchase Preferred Stock</U>. The issuance and sale of the Securities as contemplated hereby will not cause any holder
of any shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or
other rights to purchase capital stock or any other securities of the Company to have any right to acquire any shares of preferred stock
of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(fff)</FONT>
<U>No Contract Terminations</U>. Neither the Company nor any of its Subsidiaries has sent or received any communication regarding termination
of, or intent not to renew, any of the contracts or agreements referred to or described in the Registration Statement, the Time of Sale
Prospectus or the Prospectus, and no such termination or non-renewal has been threatened by the Company or any of its Subsidiaries or,
to the Company&rsquo;s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not
been rescinded as of the date hereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ggg)</FONT>
<U>Dividend Restrictions</U>. No Subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying dividends
to the Company, or from making any other distribution with respect to such Subsidiary&rsquo;s equity securities or from repaying to the
Company or any other Subsidiary of the Company any amounts that may from time to time become due under any loans or advances to such
Subsidiary from the Company or from transferring any property or assets to the Company or to any other Subsidiary.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hhh)</FONT>
<U>Maintenance of Rating</U>. Neither the Company nor its Subsidiaries have any debt securities or preferred stock that are rated by
any &ldquo;nationally recognized statistical rating agency&rdquo; (as defined in Section 3(a)(62) of the 1934 Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate signed by any officer of the Company or any of its Subsidiaries and delivered to any Underwriter or to counsel for the Underwriters
in connection with the offering, or the purchase and sale, of the Securities shall be deemed a representation and warranty by the Company
to each Underwriter as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a reasonable basis for making each of the representations set forth in this Section 1. The Company acknowledges that the
Underwriters and, for purposes of the opinions to be delivered pursuant to Section 5 hereof, counsel to the Company and counsel to the
Underwriters, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 2.</FONT> <U>Sale and Delivery to Underwriters; Closing</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Closing Securities</U>. On the basis of the representations and warranties herein contained and subject to the terms and conditions
herein set forth, the Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not
jointly, agrees to purchase from the Company, at the price per share set forth in <U>Schedule&nbsp;A</U>, that number of Closing Shares
and Pre-Funded Warrants, if any, set forth in <U>Schedule&nbsp;A</U> opposite the name of such Underwriter, plus any additional number
of Closing Shares which such Underwriter may become obligated to purchase pursuant to the provisions of Section 10 hereof, subject, in
each case, to such adjustments among the Underwriters as the Representative in its sole discretion shall make to eliminate any sales
or purchases of fractional shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Option Shares</U>. In addition, on the basis of the representations and warranties herein contained and subject to the terms and conditions
herein set forth, the Company hereby grants an option to the Underwriters, severally and not jointly, to purchase up to an additional
838,851 shares of Common Stock, at the price per share set forth in <U>Schedule&nbsp;A</U>, less an amount per share equal to any dividends
or distributions declared by the Company and payable on the Closing Shares but not payable on the Option Shares. The option hereby granted
may be exercised for 30&nbsp;days after the date hereof and may be exercised in whole or in part at any time from time to time upon notice
by the Representative to the Company setting forth the number of Option Shares as to which the several Underwriters are then exercising
the option and the time and date of payment and delivery for such Option Shares. Any such time and date of delivery (a &ldquo;<U>Date
of Delivery</U>&rdquo;) shall be determined by the Representative, but any Date of Delivery after the Closing Time shall not be later
than seven full business days nor earlier than two full business days after the exercise of said option, nor in any event prior to the
Closing Time. If the option is exercised as to all or any portion of the Option Shares, each of the Underwriters, acting severally and
not jointly, will purchase that proportion of the total number of Option Shares then being purchased which the number of Closing Shares
and Pre-Funded Warrants, if any, set forth in <U>Schedule A</U> opposite the name of such Underwriter bears to the total number of Closing
Shares and Pre-Funded Warrants, if any, subject, in each case, to such adjustments as the Representative in its sole discretion shall
make to eliminate any sales or purchases of fractional shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>
<U>Payment</U>. Payment of the purchase price for, and delivery of certificates or security entitlements for, the Closing Shares and
Pre-Funded Warrants shall be made at the offices of Underwriter&rsquo;s Counsel, or at such other place as shall be agreed upon by the
Representative and the Company, at 10:00&nbsp;A.M. (New York City time) on the first (second, if the pricing occurs after 4:00 P.M. (New
York City time) on any given day) business day after the date hereof (unless postponed in accordance with the provisions of Section&nbsp;10),
or such other time not later than ten business days after such date as shall be agreed upon by the Representative and the Company (such
time and date of payment and delivery being herein called &ldquo;<U>Closing Time</U>&rdquo;). Delivery of the Closing Shares at the Closing
Time shall be made through the facilities of The Depository Trust Company unless the Representative shall otherwise instruct. The Pre-Funded
Warrants shall be delivered to the Representative in definitive form, registered in such names and in such denominations as the Representative
shall request in writing not later than the Closing Time. The Pre-Funded Warrants will be made available for inspection by the Representative
on the business day prior to the Closing Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in the event that any or all of the Option Shares are purchased by the Underwriters, payment of the purchase price for, and
delivery of certificates or security entitlements for, such Option Shares shall be made at the above-mentioned offices, or at such other
place as shall be agreed upon by the Representative and the Company, on each Date of Delivery as specified in the notice from the Representative
to the Company. Delivery of the Option Shares on each such Date of Delivery shall be made through the facilities of The Depository Trust
Company unless the Representative shall otherwise instruct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
shall be made to the Company by wire transfer of immediately available funds to a bank account designated by the Company, against delivery
to the Representative for the respective accounts of the Underwriters of certificates or security entitlements for the Securities to
be purchased by them. It is understood that each Underwriter has authorized the Representative, for its account, to accept delivery of,
receipt for, and make payment of the purchase price for, the Closing Shares, the Pre-Funded Warrants and the Option Shares, if any, which
it has agreed to purchase. Titan Partners, individually and not as representative of the Underwriters, may (but shall not be obligated
to) make payment of the purchase price for the Closing Shares, the Pre-Funded Warrants, if any, or the Option Shares, if any, to be purchased
by any Underwriter whose funds have not been received by the Closing Time or the relevant Date of Delivery, as the case may be, but such
payment shall not relieve such Underwriter from its obligations hereunder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>
<U>Underwriter Warrants</U>. The Company hereby agrees to issue to the Representative (and/or its affiliates, employees or third-party
designees) at the Closing Time and each Date of Delivery, if any, warrants (&ldquo;<U>Underwriter Warrants</U>&rdquo;) for the purchase
of an aggregate of a number of shares of Common Stock (the &ldquo;<U>Underwriter Warrant Shares</U>&rdquo;), representing 5% of the Closing
Shares and Pre-Funded Warrants, if any, sold at the Closing Time and 5% of the Option Shares sold at each Date of Delivery, if any. The
Underwriter Warrants, in form and substance acceptable to the Representative, shall be exercisable, in whole or in part, immediately
upon issuance and expire on the five-year anniversary of the date of this Agreement at an initial exercise price per share of Common
Stock of $7.20. Delivery of the Underwriter Warrants shall be made at the Closing Time and each Date of Delivery, if any, and shall be
issued in the name or names and in such authorized denominations as the Representative may request.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 3.</FONT> <U>Covenants of the Company</U>. The Company covenants with each Underwriter
as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Compliance with Securities Regulations and Commission Requests</U>. The Company, subject to Section 3(b), will comply with the requirements
of Rule 430B, and will notify the Representative as soon as practicable, and confirm the notice in writing, (i) when any post-effective
amendment to the Registration Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed,
(ii)&nbsp;of the receipt of any comments from the Commission, (iii)&nbsp;of any request by the Commission for any amendment to the Registration
Statement or any amendment or supplement to the Prospectus (including any document incorporated by reference therein) or for additional
information, (iv)&nbsp;of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement
or any post-effective amendment or of any order preventing or suspending the use of any preliminary prospectus or the Prospectus, or
of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the initiation or threatening
of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of the 1933 Act concerning the Registration
Statement and (v) if the Company becomes the subject of a proceeding under Section 8A of the 1933 Act in connection with the offering
of the Securities. The Company will effect all filings required under Rule 424(b), in the manner and within the time period required
by Rule 424(b) (without reliance on Rule 424(b)(8)), and will take such steps as it deems necessary to ascertain promptly whether the
form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not,
it will promptly file such prospectus. The Company will make every reasonable effort to prevent the issuance of any stop order, prevention
or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Continued Compliance with Securities Laws</U>. The Company will comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act and
the 1934 Act Regulations so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and in
the Registration Statement, the General Disclosure Package and the Prospectus. If at any time when a prospectus relating to the Securities
is (or, but for the exception afforded by Rule 172 of the 1933 Act Regulations (&ldquo;<U>Rule 172</U>&rdquo;), would be) required by
the 1933 Act to be delivered in connection with sales of the Securities or any event shall occur or condition shall exist as a result
of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i)&nbsp;amend the Registration Statement
in order that the Registration Statement will not include an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading, (ii) amend or supplement the General Disclosure Package
or the Prospectus in order that the General Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of
the circumstances existing at the time it is delivered to a purchaser or (iii) amend the Registration Statement or amend or supplement
the General Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the 1933 Act or the
1933 Act Regulations, the Company will promptly (A) give the Representative notice of such event, (B) prepare any amendment or supplement
as may be necessary to correct such statement or omission or to make the Registration Statement, the General Disclosure Package or the
Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representative
with copies of any such amendment or supplement and (C) file with the Commission any such amendment or supplement; provided that the
Company shall not file or use any such amendment or supplement to which the Representative or counsel for the Underwriters shall reasonably
object. The Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters may reasonably
request. The Company has given the Representative notice of any filings made pursuant to the 1934 Act or the 1934 Act Regulations within
48 hours prior to the Applicable Time; the Company will give the Representative notice of its intention to make any such filing from
the Applicable Time to the Closing Time and will furnish the Representative with copies of any such documents a reasonable amount of
time prior to such proposed filing, as the case may be, and will not file or use any such document to which the Representative or counsel
for the Underwriters shall reasonably object.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>
<U>Delivery of Registration Statements</U>. The Company has furnished or will deliver to the Representative and counsel for the Underwriters,
without charge, signed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits filed
therewith or incorporated by reference therein and documents incorporated or deemed incorporated by reference therein) and signed copies
of all consents and certificates of experts, and will also deliver to the Representative, without charge, a conformed copy of the Registration
Statement as originally filed and each amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration
Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof
filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>
<U>Delivery of Prospectuses</U>. The Company has delivered to each Underwriter, without charge, as many copies of each preliminary prospectus
as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted by the 1933
Act. The Company will furnish to each Underwriter, without charge, during the period when a prospectus relating to the Securities is
(or, but for the exception afforded by Rule 172, would be) required to be delivered under the 1933 Act, such number of copies of the
Prospectus (as amended or supplemented) as such Underwriter may reasonably request. The Prospectus and any amendments or supplements
thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant
to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT>
<U>Blue Sky Qualifications</U>. The Company will use its best efforts, in cooperation with the Underwriters, to qualify the Securities
for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representative
may designate and to maintain such qualifications in effect so long as required to complete the distribution of the Securities; provided,
however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation
or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing
business in any jurisdiction in which it is not otherwise so subject.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT>
<U>Rule 158</U>. The Company will timely file such reports pursuant to the 1934 Act as are necessary in order to make generally available
to its securityholders as soon as practicable an earning statement for the purposes of, and to provide to the Underwriters the benefits
contemplated by, the last paragraph of Section 11(a) of the 1933 Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT>
<U>Use of Proceeds</U>. The Company will use the net proceeds received by it from the sale of the Securities in all material respects
in the manner specified in the Registration Statement, the General Disclosure Package and the Prospectus under the heading &ldquo;Use
of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT>
<U>Listing</U>. The Company will use its best efforts to effect and maintain the listing of the Common Stock (including the Closing Shares
and the Warrant Shares and Option Shares, if any) on the Nasdaq Stock Market LLC.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT>
<U>Restriction on Sale of Securities</U>. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT>
From the date hereof until 60 days following the Closing Time, the Company will not, without the prior written consent of the Representative,
(i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock or file or confidentially submit any registration statement under the
1933 Act with respect to any of the foregoing, (ii)&nbsp;enter into any swap or any other agreement or any transaction that transfers,
in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any such swap or transaction
described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or
(iii) publicly announce an intention to effect any such swap, agreement or other transaction described in clauses (i) and (ii). The foregoing
sentence shall not apply to (A) the Securities to be sold hereunder; (B) any shares of Common Stock issued by the Company upon the exercise
of an option or warrant or the conversion of a convertible security outstanding on the date hereof and referred to in the Registration
Statement, the General Disclosure Package and the Prospectus; (C) any shares of Common Stock issued or options to purchase Common Stock
granted pursuant to existing employee benefit plans of the Company referred to in the Registration Statement, the General Disclosure
Package and the Prospectus; (D) any shares of Common Stock issued pursuant to any existing non-employee director stock plan or dividend
reinvestment plan referred to in the Registration Statement, the General Disclosure Package and the Prospectus; or (E) the filing by
the Company of any registration statement on Form S-8 or a successor form thereto.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT>
From the date hereof until 60 days following the Closing Time, without the prior consent of the Representative, the Company shall be
prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock
or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;Variable Rate Transaction&rdquo;
means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price
or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common
Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that
is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified
or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters
into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may
issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless
of whether such agreement is subsequently canceled. Any Underwriter shall be entitled to obtain injunctive relief against the Company
to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT>
Notwithstanding the foregoing, this Section 3(i) shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance. &ldquo;Exempt Issuance&rdquo; means the issuance of (a) shares of Common Stock, restricted stock units or
options to employees, officers or directors of the Company pursuant to any equity incentive plan duly adopted for such purpose by a majority
of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established
for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities
issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding
on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of
such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith within 90 days following
the Closing Time, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT>
<U>Reporting Requirements</U>. The Company, during the period when a Prospectus relating to the Securities is (or, but for the exception
afforded by Rule 172, would be) required to be delivered under the 1933 Act, will file all documents required to be filed with the Commission
pursuant to the 1934 Act within the time periods required by the 1934 Act and 1934 Act Regulations. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT>
<U>Issuer Free Writing Prospectuses</U>. The Company agrees that, unless it obtains the prior written consent of the Representative,
it will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission or
retained by the Company under Rule 433; provided that the Representative will be deemed to have consented to the Issuer Free Writing
Prospectuses listed on <U>Schedule&nbsp;B-2</U> hereto and any &ldquo;road show that is a written communication&rdquo; within the meaning
of Rule 433(d)(8)(i) that has been reviewed by the Representative. The Company represents that it has treated or agrees that it will
treat each such free writing prospectus consented to, or deemed consented to, by the Representative as an &ldquo;issuer free writing
prospectus,&rdquo; as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with
respect thereto, including timely filing with the Commission where required, legending and record keeping. If at any time following issuance
of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration Statement, any preliminary prospectus or the Prospectus
or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will
promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to
eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT>
<U>Testing-the-Waters Materials</U>. If at any time following the distribution of any Written Testing-the-Waters Communication there
occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include
an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representative
and will promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such
untrue statement or omission.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT>
<U>Reservation of Shares</U>. The Company shall, at all times while any Pre-Funded Warrants are outstanding, reserve and keep available
out of the aggregate of its authorized but unissued and otherwise unreserved shares of Common Stock, solely for the purpose of enabling
it to issue Warrant Shares upon exercise of such Pre-Funded Warrants, the number of Warrant Shares that are initially issuable and deliverable
upon the exercise of the then-outstanding Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 4.</FONT> <U>Payment of Expenses</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Expenses</U>. The Company hereby agrees to pay on each of the Closing Time and each Closing Time related to Option Shares, if any,
to the extent not paid at the Closing Time, all expenses associated with the Offering or incident to the performance of the obligations
of the Company under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration
of the Securities to be sold in the Offering (including the Option Shares and the costs of reproducing and distributing each of the Pre-Funded
Warrants) with the Commission; (b) all FINRA Public Offering Filing System fees associated with the review of the Offering by FINRA;
(c) the fees and expenses incurred in connection with the listing of the Closing Shares, Warrant Shares and Option Shares on the Nasdaq
Stock Market LLC and such other stock exchanges as the Company and the Representative together determine; (d) all fees, expenses and
disbursements relating to the registration or qualification of such Securities under the &ldquo;blue sky&rdquo; securities laws of such
states and other foreign jurisdictions as the Representative may reasonably designate (including, without limitation, all filing and
registration fees, and the fees and expenses of blue sky counsel); (e) the costs of all mailing and printing of the underwriting documents
(including, without limitation, the Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters,
Selected Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney), Registration Statements, Prospectuses and
all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses as the Representative may reasonably
deem necessary; (f) the costs and expenses of the Company&rsquo;s public relations firm; (g) the costs of preparing, printing and delivering
the Securities; (h) the costs for &ldquo;tombstones&rdquo; and/or other commemorative items; (i) fees and expenses of the Transfer Agent
for the Securities (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the
Company); (j) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriters;
(k) the fees and expenses of the Company&rsquo;s accountants; (l) the fees and expenses of the Company&rsquo;s legal counsel and other
agents and representatives; (m) the Underwriters&rsquo; costs of mailing prospectuses to prospective investors; (n) the costs associated
with advertising the Offering in the national editions of the Wall Street Journal and New York Times after the Closing Time; (o) up to
$100,000 for the fees and expenses of Underwriter&rsquo;s Counsel; (p) the Company&rsquo;s reasonable &ldquo;road show&rdquo; expenses
for the Offering; and (q) the costs for bound volumes of the public offering materials as well as commemorative mementos and Lucite tombstones,
each of which the Company or its designee will provide within a reasonable time after the Closing in such quantities as the Underwriters
may reasonably request. The Underwriters may also deduct from the net proceeds of the Offering payable to the Company on the Closing
Time, or each Closing Time related to the Option Shares, if any, the expenses set forth herein to be paid by the Company to the Underwriters.
For the avoidance of doubt, in no event shall reimbursable expenses to the Underwriters exceed $125,000.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Termination of Agreement</U>. If this Agreement is terminated by the Representative in accordance with the provisions of Section 5,
Section 9(a)(i), Section 9(a)(iii) or Section 10 hereof, the Company shall reimburse the Underwriters for all of their reasonably documented
out-of-pocket expenses, including the reasonable and documented fees and disbursements of counsel for the Underwriters (up to an aggregate
of $125,000); provided that if this Agreement is terminated by the Representative pursuant to Section 10 hereof, the Company will have
no obligation to reimburse any defaulting Underwriter.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 5.</FONT> <U>Conditions of Underwriters&rsquo; Obligations</U>. The obligations of the
several Underwriters hereunder are subject to the accuracy of the representations and warranties of the Company contained herein or in
certificates of any officer of the Company or any of its Subsidiaries delivered pursuant to the provisions hereof, to the performance
by the Company of its covenants and other obligations hereunder, and to the following further conditions:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Effectiveness of Registration Statement</U>. The Registration Statement, including any Rule 462(b) Registration Statement, has become
effective and, at the Closing Time, no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment
thereto has been issued under the 1933 Act, no order preventing or suspending the use of any preliminary prospectus or the Prospectus
has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&rsquo;s knowledge,
contemplated; and the Company has complied with each request (if any) from the Commission for additional information to the reasonable
satisfaction of counsel to the Underwriters. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Opinion of Counsel for Company</U>. At the Closing Time, the Representative shall have received the opinion and the negative assurance
letter, each dated the Closing Time, of Shutts &amp; Bowen LLP, counsel for the Company, together with the opinion of the Law Office
of L. Jack Gibney, special counsel for the Company with respect to intellectual property matters, each in form and substance satisfactory
to the Representative.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>
<U>Opinion of Counsel for Underwriters</U>. At the Closing Time, the Representative shall have received a negative assurance letter,
dated the Closing Time, of Ellenoff Grossman &amp; Schole LLP, counsel for the Underwriters (&ldquo;<U>Underwriter&rsquo;s Counsel</U>&rdquo;),
together with signed or reproduced copies of such letters for each of the other Underwriters in form and substance satisfactory to the
Representative. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>
<U>Officers&rsquo; Certificate</U>. At the Closing Time, there shall not have been, since the date hereof or since the respective dates
as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any material adverse
change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its Subsidiaries
considered as one enterprise, whether or not arising in the ordinary course of business, and the Representative shall have received a
certificate of the principal executive officer of the Company and of the principal financial officer of the Company, dated the Closing
Time, to the effect that (i) there has been no such material adverse change, (ii)&nbsp;the representations and warranties of the Company
in this Agreement are true and correct with the same force and effect as though expressly made at and as of the Closing Time, (iii)&nbsp;the
Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing
Time, and (iv)&nbsp;no stop order suspending the effectiveness of the Registration Statement under the 1933 Act has been issued, no order
preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued and no proceedings for any of those
purposes have been instituted or are pending or, to their knowledge, contemplated.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT>
<U>Accountant&rsquo;s Comfort Letter</U>. At the time of the execution of this Agreement, the Representative shall have received from
Salberg &amp; Company, P.A. a letter, dated such date, in form and substance satisfactory to the Representative, together with signed
or reproduced copies of such letter for each of the other Underwriters containing statements and information of the type ordinarily included
in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements and certain financial information
contained in the Registration Statement, the General Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT>
<U>Bring-down Comfort Letter</U>. At the Closing Time, the Representative shall have received from Salberg &amp; Company, P.A. a letter,
dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e)
of this Section, except that the specified date referred to shall be a date not more than three business days prior to the Closing Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT>
<U>Approval of Listing</U>. The Company shall have submitted a listing of additional shares notification form to Nasdaq Stock Market
LLC with respect to the Securities and shall have received no objection thereto from Nasdaq Stock Market LLC.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT>
<U>Form of Pre-Funded Warrant</U>. The Representative shall have received a form of Pre-Funded Warrant in form and substance reasonably
acceptable to the Representative.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT>
<U>No Objection</U>. FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT>
<U>Lock-up Agreements</U>. At the date of this Agreement, the Representative shall have received an agreement substantially in the form
of <U>Exhibit&nbsp;A</U> hereto signed by all of the Company&rsquo;s directors and officers and shareholders of the Company listed on
<U>Exhibit A</U> (the &ldquo;<U>Lock-up Agreements</U>&rdquo;). The Company agrees to enforce the restrictions on transfer set forth
in Lock-up Agreements.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT>
<U>[Intentionally omitted</U>]</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT>
<U>[Intentionally omitted</U>]</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT>
<U>Conditions to Purchase of Option Shares</U>. In the event that the Underwriters exercise their option provided in Section&nbsp;2(b)
hereof to purchase all or any portion of the Option Shares, the representations and warranties of the Company contained herein and the
statements in any certificates furnished by the Company and any of its Subsidiaries hereunder shall be true and correct as of each Date
of Delivery and, at the relevant Date of Delivery, the Representative shall have received:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT>
<U>Officers&rsquo; Certificate</U>. A certificate, dated such Date of Delivery, of the principal executive officer of the Company and
of the principal financial officer of the Company confirming that the certificate delivered at the Closing Time pursuant to Section&nbsp;5(d)
hereof remains true and correct as of such Date of Delivery.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT>
<U>Opinion of Counsel for Company</U>. If requested by the Representative, the opinion, and negative assurance letter, of Shutts &amp;
Bowen LLP, counsel for the Company, together with the opinion of the Law Office of L. Jack Gibney, special counsel for the Company with
respect to intellectual property matters, each in form and substance satisfactory to counsel for the Underwriters, dated such Date of
Delivery, relating to the Option Shares to be purchased on such Date of Delivery and otherwise to the same effect as the opinions and
negative assurance letter required by Section&nbsp;5(b) hereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT>
<U>Opinion of Counsel for Underwriters</U>. If requested by the Representative, a negative assurance letter, of Underwriter&rsquo;s Counsel,
dated such Date of Delivery, relating to the Option Shares to be purchased on such Date of Delivery and otherwise to the same effect
as the opinion and negative assurance letter required by Section&nbsp;5(c) hereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT>
<U>Bring-down Comfort Letter</U>. If requested by the Representative, a letter from Salberg &amp; Company, P.A., in form and substance
satisfactory to the Representative and dated such Date of Delivery, substantially in the same form and substance as the letter furnished
to the Representative pursuant to subsection (f) of this Section, except that the &ldquo;specified date&rdquo; in the letter furnished
pursuant to this paragraph shall be a date not more than three business days prior to such Date of Delivery.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT>
<U>[Intentionally omitted</U>]</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT>
<U>Additional Documents</U>. At the Closing Time and at each Date of Delivery (if any), counsel for the Underwriters shall have been
furnished with such other documents and opinions as they may reasonably require for the purpose of enabling them to pass upon the issuance
and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of the representations or warranties,
or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance
and sale of the Securities as herein contemplated shall be reasonably satisfactory in form and substance to the Representative and counsel
for the Underwriters.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT>
<U>Termination of Agreement</U>. If any condition specified in this Section shall not have been fulfilled when and as required to be
fulfilled, this Agreement, or, in the case of any condition to the purchase of Option Shares on a Date of Delivery which is after the
Closing Time, the obligations of the several Underwriters to purchase the relevant Option Shares, may be terminated by the Representative
by notice to the Company at any time at or prior to Closing Time or such Date of Delivery, as the case may be, and such termination shall
be without liability of any party to any other party except as provided in Section 4 and except that Sections 1, 4, 6, 7, 8, 13, 14 and
15 shall survive any such termination and remain in full force and effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 6.</FONT> <U>Indemnification</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Indemnification of Underwriters</U>. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates (as such term
is defined in Rule 501(b) under the 1933 Act (each, an &ldquo;<U>Affiliate</U>&rdquo;)), its selling agents and each person, if any,
who controls any Underwriter within the meaning of Section&nbsp;15 of the 1933 Act or Section 20 of the 1934 Act as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT>
against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including any information deemed
to be a part thereof pursuant to Rule 430B, or the omission or alleged omission therefrom of a material fact required to be stated therein
or necessary to make the statements therein not misleading or arising out of any untrue statement or alleged untrue statement of a material
fact included (A) in any preliminary prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, the
General Disclosure Package or the Prospectus (or any amendment or supplement thereto), or (B) in any materials or information provided
to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities (&ldquo;<U>Marketing
Materials</U>&rdquo;), including any roadshow or investor presentations made to investors by the Company (whether in person or electronically),
or the omission or alleged omission in any preliminary prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters
Communication, the General Disclosure Package, the Prospectus (or any amendment or supplement thereto) or in any Marketing Materials
of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT>
against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in
settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any
claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject
to Section 6(d) below) any such settlement is effected with the written consent of the Company; and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT>
against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by the Representative), reasonably
incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency
or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission, to the extent that any such expense is not paid under (i) or (ii) above;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided,
however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of
any untrue statement or omission or alleged untrue statement or omission made in the Registration Statement (or any amendment thereto),
including any information deemed to be a part thereof pursuant to Rule 430B, the General Disclosure Package or the Prospectus (or any
amendment or supplement thereto) in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Indemnification of Company</U>, Directors and Officers. Each Underwriter severally agrees to indemnify and hold harmless the Company,
its directors, each of its officers who signed the Registration Statement, and each person, if any, who controls the Company within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any and all loss, liability, claim, damage, and expense
described in the indemnity contained in subsection (a) of this Section, as incurred, but only with respect to untrue statements or omissions,
or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto), including any information deemed
to be a part thereof pursuant to Rule 430B, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto)
in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>
<U>Actions against Parties; Notification</U>. Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify
an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced
as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity
agreement. In the case of parties indemnified pursuant to Section 6(a) above, counsel to the indemnified parties shall be selected by
the Representative, and in the case of parties indemnified pursuant to Section 6(b) above, counsel to the indemnified parties shall be
selected by the Company. An indemnifying party may participate at its own expense in the defense of any such action; provided, however,
that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified
party. In no event shall the indemnifying parties be liable for the reasonable fees and expenses of more than one counsel (in addition
to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar
or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall,
without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect
to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever
in respect of which indemnification or contribution could be sought under this Section 6 or Section 7 hereof (whether or not the indemnified
parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release
of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include
a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>
<U>Settlement without Consent if Failure to Reimburse</U>. If at any time an indemnified party shall have requested an indemnifying party
to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement
of the nature contemplated by Section 6(a)(ii) effected without its written consent if (i) such settlement is entered into more than
45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of
the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not
have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 7.</FONT> <U>Contribution</U>. If the indemnification provided for in Section&nbsp;6 hereof
is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims,
damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities,
claims, damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the
relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities
pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as
is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company,
on the one hand, and of the Underwriters, on the other hand, in connection with the statements or omissions which resulted in such losses,
liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, in connection with the offering
of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from
the offering of the Securities pursuant to this Agreement (before deducting expenses) received by the Company, on the one hand, and the
total underwriting discount received by the Underwriters, on the other hand, in each case as set forth on the cover of the Prospectus,
bear to the aggregate public offering price of the Securities as set forth on the cover of the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fault of the Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to, among other
things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact
relates to information supplied by the Company or by the Underwriters and the parties&rsquo; relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined
by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which
does not take account of the equitable considerations referred to above in this Section 7. The aggregate amount of losses, liabilities,
claims, damages and expenses incurred by an indemnified party and referred to above in this Section 7 shall be deemed to include any
legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation,
or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any
such untrue or alleged untrue statement or omission or alleged omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the provisions of this Section 7, no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and
commissions received by such Underwriter in connection with the Securities underwritten by it and distributed to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Section 7, each person, if any, who controls an Underwriter within the meaning of Section 15 of the 1933 Act or Section
20 of the 1934 Act and each Underwriter&rsquo;s Affiliates and selling agents shall have the same rights to contribution as such Underwriter,
and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls
the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution
as the Company. The Underwriters&rsquo; respective obligations to contribute pursuant to this Section 7 are several in proportion to
the number of Closing Shares and Pre-Funded Warrants, if any, set forth opposite their respective names in <U>Schedule&nbsp;A</U> hereto
and not joint.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 8.</FONT> <U>Representations, Warranties and Agreements to Survive</U>. All representations,
warranties and agreements contained in this Agreement or in certificates of officers of the Company or any of its Subsidiaries submitted
pursuant hereto, shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any
Underwriter or its Affiliates or selling agents, any person controlling any Underwriter, its officers or directors or any person controlling
the Company and (ii) delivery of and payment for the Securities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 9.</FONT> <U>Termination of Agreement</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
<U>Termination</U>. The Representative may terminate this Agreement, by notice to the Company, at any time at or prior to the Closing
Time (i) if there has been, in the judgment of the Representative, since the time of execution of this Agreement or since the respective
dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any material
adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and
its Subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business, or (ii)&nbsp;if there has occurred
any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities
or escalation thereof or other calamity or crisis or any change or development involving a prospective change in U.S. or international
political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Representative,
impracticable or inadvisable to proceed with the completion of the offering or to enforce contracts for the sale of the Securities, or
(iii)&nbsp;if trading in any securities of the Company has been suspended or materially limited by the Commission or the Nasdaq Stock
Market LLC, or (iv) if trading generally on the NYSE MKT or the New York Stock Exchange or in the Nasdaq Capital Market has been suspended
or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by
any of said exchanges or by order of the Commission, FINRA or any other governmental authority, or (v)&nbsp;a material disruption has
occurred in commercial banking or securities settlement or clearance services in the United States or with respect to Clearstream or
Euroclear systems in Europe, or (vi) if a banking moratorium has been declared by either Federal or New York authorities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
<U>Liabilities</U>. If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party
to any other party except as provided in Section 4 hereof, and provided further that Sections 1, 4, 6, 7, 8, 14, 15 and 16 shall survive
such termination and remain in full force and effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 10.</FONT> <U>Default by One or More of the Underwriters</U>. If one or more of the Underwriters shall fail at
the Closing Time or a Date of Delivery to purchase the Securities which it or they are obligated to purchase under this Agreement (the
&ldquo;<U>Defaulted Securities</U>&rdquo;), the Representative shall have the right, within 24&nbsp;hours thereafter, to make arrangements
for one or more of the non-defaulting Underwriters, or any other underwriters, to purchase all, but not less than all, of the Defaulted
Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representative shall not have
completed such arrangements within such 24-hour period, then:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>
if the number of Defaulted Securities does not exceed 10% of the number of Closing Shares and Pre-Funded Warrants, collectively, to be
purchased on such date, each of the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount
thereof in the proportions that their respective underwriting obligations hereunder bear to the underwriting obligations of all non-defaulting
Underwriters, or</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
if the number of Defaulted Securities exceeds 10% of the number of Closing Shares and Pre-Funded Warrants, collectively, to be purchased
on such date, this Agreement or, with respect to any Date of Delivery which occurs after the Closing Time, the obligation of the Underwriters
to purchase, and the Company to sell, the Option Shares to be purchased and sold on such Date of Delivery shall terminate without liability
on the part of any non-defaulting Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
action taken pursuant to this Section shall relieve any defaulting Underwriter from liability in respect of its default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any such default which does not result in a termination of this Agreement or, in the case of a Date of Delivery which is
after the Closing Time, which does not result in a termination of the obligation of the Underwriters to purchase and the Company to sell
the relevant Option Shares, as the case may be, either the (i) Representative or (ii) the Company shall have the right to postpone Closing
Time or the relevant Date of Delivery, as the case may be, for a period not exceeding seven days in order to effect any required changes
in the Registration Statement, the General Disclosure Package or the Prospectus or in any other documents or arrangements. As used herein,
the term &ldquo;Underwriter&rdquo; includes any person substituted for an Underwriter under this Section 10.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 11.</FONT> <U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to
be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (i) the time of transmission, if
such notice or communication is delivered via e-mail attachment at the email address set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a day on which the Nasdaq Stock Market LLC is open for trading (&ldquo;<U>Trading Day</U>&rdquo;),
(ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail attachment at the e-mail
address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City
time) on any Trading Day, (iii) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (iv) upon actual receipt by the party to whom such notice is required to be given. The address for such
notices and communications shall be as set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
sent to the Representative or any Underwriter, shall be delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
Partners Group LLC, a division of American Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
World Trade Center, 29th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10007</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Adam Sands</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
notices@titanpartnersgrp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to Underwriters&rsquo; counsel (which shall not constitute notice) at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellenoff
Grossman &amp; Schole LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1345
Avenue of the Americas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10105</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Matthew Bernstein, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
mbernstein@egsllp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
sent to the Company, shall be delivered personally, by e-mail, or sent by a nationally recognized overnight courier service to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duos
Technologies Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7660
Centurion Parkway, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacksonville,
Florida 33256</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Adrian Goldfarb</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
agg@duostech.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to the Company counsel (which shall not constitute notice) at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shutts
&amp; Bowen LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200
South Biscayne Boulevard, Suite 4100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miami,
Florida 33131</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
J. Thomas Cookson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
tcookson@shutts.com</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 12.</FONT> <U>No Advisory or Fiduciary Relationship</U>. The Company acknowledges and agrees that (a) the purchase
and sale of the Securities pursuant to this Agreement, including the determination of the public offering price of the Securities and
any related discounts and commissions, is an arm&rsquo;s-length commercial transaction between the Company, on the one hand, and the
several Underwriters, on the other hand, (b) in connection with the offering of the Securities and the process leading thereto, each
Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company, any of its Subsidiaries or
their respective stockholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or
fiduciary responsibility in favor of the Company with respect to the offering of the Securities or the process leading thereto (irrespective
of whether such Underwriter has advised or is currently advising the Company or any of its Subsidiaries on other matters) and no Underwriter
has any obligation to the Company with respect to the offering of the Securities except the obligations expressly set forth in this Agreement,
(d) the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ
from those of the Company and (e) the Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to
the offering of the Securities and the Company has consulted its own respective legal, accounting, regulatory and tax advisors to the
extent it deemed appropriate. </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 13.</FONT> <U>Parties</U>. This Agreement shall each inure to the benefit of and be binding upon the Underwriters
and the Company and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to
give any person, firm or corporation, other than the Underwriters and the Company and their respective successors and the controlling
persons and officers and directors referred to in Sections&nbsp;6 and 7 and their heirs and legal representatives, any legal or equitable
right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and
provisions hereof are intended to be for the sole and exclusive benefit of the Underwriters and the Company and their respective successors,
and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person,
firm or corporation. No purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely of such purchase.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 14.</FONT> <U>GOVERNING LAW</U>. <B>This agreement and any claim, controversy or dispute arising under or related
to this agreement shall be governed by, and construed in accordance with the laws of, the state of New York without regard to its choice
of law provisions.</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 15.</FONT> <U>Waiver of Trial by Jury</U>. The Company and each of the Underwriters hereby irrevocably waives,
to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating
to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 16.</FONT> <U>Consent to Jurisdiction; Waiver of Immunity</U>. Any legal suit, action or proceeding arising out
of or based upon this Agreement or the transactions contemplated hereby shall&nbsp;be instituted in (i) the federal courts of the United
States of America located in the City and County of New York, Borough of Manhattan or&nbsp;(ii) the courts of the State of New York located
in the City and County of New York, Borough of Manhattan (collectively, the &ldquo;<U>Specified Courts</U>&rdquo;), and each party irrevocably
submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court,
as to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding. Service of any process, summons,
notice or document by mail to such party&rsquo;s address set forth above shall be effective service of process for any suit, action or
other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of
any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim
in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum.
</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 17.</FONT> <U>TIME</U>. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN,
SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 18.</FONT> <U>Partial Unenforceability</U>. The invalidity or unenforceability of any Section, paragraph or provision
of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If any Section,
paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made
such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 19.</FONT> <U>Counterparts</U>. This Agreement may be executed in any number of counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be deemed to be an original, but all such counterparts
shall together constitute one and the same agreement. Counterparts may be delivered via facsimile, electronic mail (including any electronic
signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act
or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have
been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 20.</FONT> <U>Effect of Headings</U>. The headings of the sections of this Agreement have been inserted for convenience
of reference only and shall not be deemed a part of this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 21.</FONT> <U>Entire Agreement</U>. This Agreement supersedes all prior agreements and understandings (whether
written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">SECTION 22.</FONT> <U>Recognition of the U.S. Special Resolution Regimes</U>. In the event that any Underwriter that is
a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement,
and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under
the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States
or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, (A) &ldquo;BHC Act Affiliate&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and
shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k); (B) &ldquo;Covered Entity&rdquo; means any of the following: (i) a
&ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b); (ii) a &ldquo;covered
bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or (iii) a &ldquo;covered FSI&rdquo;
as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b); (C) &ldquo;Default Right&rdquo; has the meaning
assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as applicable; and
(D) &ldquo;U.S. Special Resolution Regime&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated
thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES FOLLOW]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DUOS
TECHNOLOGIES GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>/s/ Adrian G. Goldfarb&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 238.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;Adrian G. Goldfarb</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 30pt; text-indent: 238.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT>
Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
as of the date hereof</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Titan
Partners Group LLC,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>A
Division of American Capital Partners, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>/s/ Adam Sands&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>
Adam Sands</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT>
Authorized Representative </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
themselves and as Representative of the other Underwriters named in <U>Schedule&nbsp;A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock: 6,666,667</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrants: 0</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter</FONT></TD>
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of<BR>
    <U>Closing Shares</U></FONT></TD>
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of<BR>
    <U>Pre-Funded Warrants</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
    Partners Group LLC, a division of American Capital Partners, LLC&#9;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,666,667</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total&#9;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 1.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,666,667</FONT></P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 1.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
B-1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Pricing
Terms</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Share of Common Stock: $6.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters&rsquo;
Discount per Share of Common Stock: $0.42</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
B-2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Free
Writing Prospectuses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[None]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<UL STYLE="margin-top: 0in; list-style-type: disc">

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Pessin</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bleichroeder</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles P. Ferry</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ned Mavrommatis</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Craig Nixon</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank A. Lonegro</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adiran G. Goldfarb</FONT></LI>

<LI STYLE="margin: 0 0 12pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher T.
King</FONT></LI>

</UL>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF LOCK-UP AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF PRE-FUNDED WARRANT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4x1.htm
<DESCRIPTION>FORM OF UNDERWRITER WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">Exhibit 4.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF REPRESENTATIVE&rsquo;S PURCHASE
WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DUOS
TECHNOLOGIES GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><B>Warrant Shares: 333,334</B></TD>
  <TD STYLE="text-align: right; width: 50%"><B>Issue Date: August 1, 2025</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">This <B>REPRESENTATIVE&rsquo;S
PURCHASE WARRANT</B> (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, American Capital Partners, LLC or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on August 1, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Duos
Technologies Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 333,334 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 1.</FONT><U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address of 1 State Street,
Floor 30, New York, New York 10275 and an email address of eyoung@continentalstock.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Underwriting Agreement</U>&rdquo;
means that certain Underwriting Agreement (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), dated July 30, 2025, between the Company
and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representative of the several Underwriters named in Schedule
A thereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;VWAP&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock are then listed or quoted
on The New York Stock Exchange, the NYSE American or any tier of The Nasdaq Stock Market (each, a &ldquo;Trading Market&rdquo;), the daily
volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common
Stock are then listed or quoted as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) (based on a trading day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock are listed or quoted on the OTCQB or OTCQX (each as operated by
OTC Markets Group, Inc., or any successor market), the volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock are not then listed or quoted for trading on the OTCQB or OTCQX
Markets and if prices for the Common Stock are then reported in the OTC Pink Market published by OTC Markets Group Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a Common Stock as determined by an independent appraiser selected in good faith by
the Board of Directors of the Company and reasonably acceptable to the Holder, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><U></U></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U></FONT>.<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made,
in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the
Company of a duly executed PDF copy submitted by email (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the
&ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn
on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of
Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on
the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $7.20,
subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement
registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant
may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of
Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the
principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">(X) = the number of
Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares are
issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the
holding period of the Warrant Shares being issued may be tacked onto the holding period of the Warrant. The Company agrees not to take
any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Mechanics of Exercise</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-size: 10pt">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if
the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of
the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without
volume or manner of sale limitations pursuant to Rule 144 (assuming this Warrant is being exercised via cashless exercise), and otherwise
by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for
the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice
of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and
(ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
(such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case
of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, then commencing on the date that is two (2) Trading Days after
the Warrant Share Delivery Date, provided that the Warrant Shares have not been delivered, the Company shall pay to the Holder, in cash,
as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common
Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day
after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered
or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as
this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement
period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect
on the date of delivery of the Notice of Exercise. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part,
the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares,
deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this
Warrant, which new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder
the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such
exercise; <U>provided, however</U>, that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such
rescinded exercise notice concurrently with the return to the Holder of the aggregate Exercise Price paid to the Company for such Warrant
Shares and the restoration of the Holder&rsquo;s right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of
a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition
to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if
after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of
the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to
timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase
upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the
Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes
and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names
as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner
which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution
Parties&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall not have any liability for
any error by the Holder or any other Person. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one Trading
Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior
to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the
Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds
9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon
exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial
Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e)
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.</U></FONT>.<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding:
(i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity
equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued
by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii)
combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues
by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be
multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after
such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification,
the Exercise Price of this Warrant will not be adjusted in the event that the Company or any subsidiary thereof, as applicable, sells
or grants any option to purchase, or sell or any grant any right to reprice, or otherwise dispose of or issue (or announce any offer,
sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share
less than the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above,
if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Pro Rata Distribution</U>. During such time as this Warrant is outstanding, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution (other than cash) of stock or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar
transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder
shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that the Holder's right to participate
in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has
not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance
for the benefit of the Holder until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Fundamental Transaction.</U> If, at any time while this Warrant is outstanding, (i) the Company,
directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person
(other than for the purpose of changing the Company&rsquo;s name or jurisdiction of incorporation or forming or collapsing a holding company),
(ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of Company&rsquo;s assets on a consolidated basis in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities,
cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or
(v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock
(not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with
the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;Fundamental
Transaction&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction (without regard
to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;Alternate Consideration&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor
Entity&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the Underwriting Agreement in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Company and
the holders of Warrants representing at least a majority of the shares of Common Stock underlying the Warrants then outstanding (the &ldquo;Required
Holders&rdquo;) and approved by the Required Holders (without unreasonable delay) prior to such Fundamental Transaction and shall deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the
nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued
and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Holder</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other
distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption
of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries,
taken as a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange
whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email
to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to
the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)
the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of Common
Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice and provided further that no notice shall be required if the information is in
a press release disseminated by the Company or a document filed by the Company with the Commission. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to
exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4 .</U></FONT>.<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and
all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. This Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. The Holders shall pay
any reasonable cost or expense in connection with the issuance of any new Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation
hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants
are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may
be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the
initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto. The Holders shall pay any reasonable cost or expense in connection with the issuance of any new Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by
or on behalf of the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from
time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any
exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Representation by Holder</U>. The Holder, by the acceptance hereof, represents and warrants that
it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account
and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or
any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.</U></FONT>.<U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 6.</U></FONT>.<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle
the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in
Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event
shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate. The Holders shall pay any reasonable cost or expense in connection with the issuance of any
new Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action
or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may
be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Authorized Shares</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this
Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock
may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action,
including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of
all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body
having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">Before taking any action which would result in an adjustment in the number of Warrant Shares for
which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or
consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Governing Law; Venue</U>. This Warrant shall be deemed to have been executed and delivered in
New York and both this Warrant and the transactions contemplated hereby shall be governed as to validity, interpretation, construction,
effect, and in all other respects by the laws of the State of New York applicable to agreements wholly performed within the borders of
such state and without regard to the conflicts of laws principals thereof (other than Section 5-1401 of The New York General Obligations
Law). Each of the Holder and the Company: (a) agrees that any legal suit, action or proceeding arising out of or relating to this Warrant
and/or the transactions contemplated hereby shall be instituted exclusively in the Supreme Court of the State of New York, New York County,
or in the United States District Court for the Southern District of New York, (b) waives any objection which it may have or hereafter
to the venue of any such suit, action or proceeding, and (c) irrevocably consents to the jurisdiction of Supreme Court of the State of
New York, New York County, or in the United States District Court for the Southern District of New York in any such suit, action or proceeding.
Each of the Holder and the Company further agrees to accept and acknowledge service of any and all process which may be served in any
such suit, action or proceeding in the Supreme Court of the State of New York, New York County, or in the United States District Court
for the Southern District of New York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s
address or delivered by Federal Express via overnight delivery shall be deemed in every respect effective service of process upon the
Company, in any such suit, action or proceeding, and service of process upon the Holder mailed by certified mail to the Holder&rsquo;s
address or delivered by Federal Express via overnight delivery shall be deemed in every respect effective service process upon the Holder,
in any such suit, action or proceeding. THE HOLDER (ON BEHALF OF ITSELF, ITS SUBSIDIARIES AND, TO THE FULLEST EXTENT PERMITTED BY LAW,
ON BEHALF OF ITS RESPECTIVE EQUITY HOLDERS AND CREDITORS) HEREBY WAIVES ANY RIGHT HOLDER MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY
CLAIM BASED UPON, ARISING OUT OF OR IN CONNECTION WITH THIS WARRANT AND THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of
this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state
and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right
hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies.
Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>. Any and all notices or other communications or deliveries to be provided hereunder
shall be made in accordance with Section 7.3 of the Underwriting Agreement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by
the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall
give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary
damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights
and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company
and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under
applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Page Follows)<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>DUOS TECHNOLOGIES GROUP, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By:__________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 3.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">To:</FONT><B>DUOS
TECHNOLOGIES GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the
terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in">[_] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in">[_] if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified
below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Name of Investing Entity: ___________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">_______________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><I>Signature of Authorized Signatory of Investing Entity</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">_________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Date: _______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the
foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/115% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Name:</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/115% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%"><U>&#9;</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Address:</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%"><U>&#9;</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Email Address:</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Dated: _______________, ______</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s Signature:<U>&#9;</U></FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s Address:<U>&#9;</U></FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5x1.htm
<DESCRIPTION>LEGAL OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>EXHIBIT 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_mps249727070000000000000003039000000000"></A>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 83px; width: 207px"></TD>
    <TD STYLE="width: 28%">
    <P STYLE="font: 8pt Trebuchet MS, Times, Serif; margin: 0">Shutts &amp; Bowen LLP</P>
    <P STYLE="font: 8pt/9.5pt Trebuchet MS, Times, Serif; margin: 0; letter-spacing: 0.4pt">200 South Biscayne Boulevard<BR>
    Suite 4100<BR>
    Miami, FL 33131</P>
    <P STYLE="font: 8pt Trebuchet MS, Times, Serif; margin: 0">DIRECT&nbsp;&nbsp;(305) 358-6300</P>
    <P STYLE="font: 8pt Trebuchet MS, Times, Serif; margin: 0">FAX&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(305) 3581-9982</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">August 1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Duos Technologies Group, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">7660 Centurion Parkway, Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jacksonville, Florida 32256</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">We have acted as counsel
to Duos Technologies Group, Inc., a Florida corporation (the &#8220;Company&#8221;), in connection with the issuance and sale by the
Company of 6,666,667 shares (the &#8220;Shares&#8221;) of its common stock, par value $0.001 per share (the &#8220;Common
Stock&#8221;), pursuant to the Underwriting Agreement, dated July 30, 2025 (the &#8220;Underwriting Agreement&#8221;), between the
Company and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representative of the several underwriters
named in Schedule 1 thereto (the &#8220;Underwriters&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In connection with this
opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration
Statement on Form S-3 (File No. 333-272603) which was filed with the Securities and Exchange Commission (the
&#8220;Commission&#8221;) on June 12, 2023, and Amendment No. 1 thereto which was filed with the Commission on June 20, 2023, under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;); (ii) the Registration Statement on Form S-3MEF (File No.
333-289106) which was filed with the Commission on July 30, 2025, (iii) the Underwriting Agreement; (iv) the prospectus, dated June
21, 2023 (the &#8220;Base Prospectus&#8221;), which forms part of the Registration Statement; (v) the preliminary prospectus
supplement, filed with the Commission on July 30, 2025 and the prospectus supplement, filed with the Commission on August 1, 2025 (collectively, the &#8220;Prospectus Supplement&#8221;); (vi) the Amended and Restated Articles of Incorporation of the
Company, as amended, as currently in effect; (vii) the Amended and Restated By-Laws of the Company, as amended, as currently in
effect; and (viii) certain resolutions and minutes of meetings of the Board of Directors of the Company and the Pricing Committee
thereof, relating to the Registration Statement (including the Base Prospectus), the Prospectus Supplement, the Shares, the
Underwriting Agreement and the transactions contemplated thereby. We have also examined originals or copies, certified or otherwise
identified to our satisfaction, of such records of the Company and such agreements, certificates of public officials, certificates
of officers or other representatives of the Company and others, and such other documents, certificates and records as we have deemed
necessary or appropriate as a basis for the opinion set forth herein.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In our examination, we have
assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us
as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified, conformed or
photostatic copies, and the authenticity of the originals of such copies. In making our examination of executed documents, we have assumed
that the parties thereto, other than the Company, had the power, corporate or other, to enter into and perform all obligations thereunder
and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties
of such documents and the validity and binding effect thereof on such parties. As to any facts material to the opinion expressed herein
which we have not independently established or verified, we have relied upon statements and representations of officers and other representatives
of the Company and others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Based upon the foregoing and
subject to the limitations set forth below, we are of the opinion that, the Shares have been duly authorized and, when issued and paid
for as described in the Prospectus Supplement and pursuant to the Underwriting Agreement, will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">We express no opinion as to
matters governed by laws of any jurisdiction other than the laws of the State of Florida and the federal laws of the United States of
America, as in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">We are opining only as to
matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is rendered as of the date
hereof and is based upon currently existing statutes, rules, regulations and judicial decisions. We disclaim any obligation to advise
you of any change in any of these sources of law or subsequent legal or factual developments that affect any matters or opinions set forth
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">We hereby consent to the incorporation
by reference of this letter as an exhibit to the Form 8-K being filed in connection with the entry into the Underwriting Agreement and
to any and all references to our firm in the Prospectus Supplement. In giving our consent, we do not thereby admit that we are in the
category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.45pc">Very truly yours,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pc 0 0 0.45pc"><I>/s/ Shutts &amp; Bowen LLP</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.45pc">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -3pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -3pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -3pc"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -3pc">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99x1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;<IMG SRC="image_001.gif" ALT=""></TD>
  <TD STYLE="width: 50%"><P STYLE="text-align: right; margin: 0; font: 12pt Cambria, Times, Serif">FOR IMMEDIATE RELEASE</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Duos Technologies
Group, Inc. Announces Proposed Public Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">JACKSONVILLE, FL, July 30,
2025 &mdash; Duos Technologies Group, Inc. (&ldquo;Duos&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: DUOT) a provider of adaptive, versatile
and streamlined Edge Data Center (&ldquo;EDC&rdquo;) solutions tailored to meet evolving needs in any environment, today announced that
it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject
to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms
of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The net proceeds from the
offering will be used to expand, accelerate, and further commercialize the Company&rsquo;s Edge Data Center business. With this funding,
the Company is expected to be fully capitalized to execute on its substantial backlog and advance to Stage 2 of its EDC strategy, which
is the development and deployment of more than 65 edge data centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Titan Partners Group, a division
of American Capital Partners, is acting as the sole bookrunner for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The offering is being made
pursuant to a shelf registration statement on Form S-3 (File No. 333-272603) filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;)
on June 12, 2023, and declared effective by the SEC on June 21, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">A preliminary prospectus
supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC&rsquo;s website
at www.sec.gov. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering, when available,
may also be obtained by contacting Titan Partners Group LLC, a division of American Capital Partners, LLC, 4 World Trade Center, 29th
Floor, New York, NY 10007, by phone at (929) 833-1246 or by email at prospectus@titanpartnersgrp.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">This press release shall
not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in
any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 2pt 0 0">About Duos Technologies Group, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Duos Technologies Group, Inc. (Nasdaq: DUOT), based
in Jacksonville, Florida, through its wholly owned subsidiaries, Duos Technologies, Inc., Duos Edge AI, Inc., and Duos Energy Corporation,
designs, develops, deploys and operates intelligent technology solutions for Machine Vision and Artificial Intelligence (&ldquo;AI&rdquo;)
applications including real-time analysis of fast-moving vehicles, Edge Data Centers and power consulting. For more information, visit
www.duostech.com , www.duosedge.ai and www.duosenergycorp.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I>Forward- Looking Statements</I></B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><I>This news release includes
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, regarding, among other things our expectations regarding the completion, terms, size, and timing of
the public offering, and with respect to granting the underwriters a 30-day option to purchase additional shares, in addition to our plans,
strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in
or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions
or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking
statements contained in this news release may be identified by the use of forward-looking words such as &quot;believe,&quot; &quot;expect,&quot;
&quot;anticipate,&quot; &quot;should,&quot; &quot;planned,&quot; &quot;will,&quot; &quot;may,&quot; &quot;intend,&quot; &quot;estimated,&quot;
and &quot;potential,&quot; among others. Important factors that could cause actual results to differ materially from the forward-looking
statements we make in this news release include risks and uncertainties related to completion of the public offering on the anticipated
terms or at all, market conditions and the satisfaction of customary closing conditions related to the public offering and those set forth
in reports or documents that we file from time to time with the United States Securities and Exchange Commission. We do not undertake
or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any
change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required
by law. All forward-looking statements attributable to Duos Technologies Group, Inc. or a person acting on its behalf are expressly qualified
in their entirety by this cautionary language.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A"><B>Contacts </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A"><B>Corporate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A">Fei Kwong, Director, Corporate Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #26282A">Duos Technologies Group, Inc. (Nasdaq: DUOT)<BR>
904-652-1625<B><BR>
</B></FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">fk@duostech.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ex99x2.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">Exhibit 99.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;<IMG SRC="image_001.gif" ALT=""></TD>
  <TD STYLE="width: 50%"><P STYLE="text-align: right; margin: 0; font: 12pt Cambria, Times, Serif">FOR IMMEDIATE RELEASE</P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Duos Technologies Group, Inc. Announces Pricing
of $40 Million Upsized and Oversubscribed Public Offering of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>With over $40 million in expected cash on hand,
Duos is now fully capitalized to fulfill its $50 million revenue pipeline and advance deployment of an additional 65 Edge Data Centers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Offering included primary participation from
fundamental institutional investors, including a leading long-only mutual fund, several preeminent global investment managers, and existing
investors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">JACKSONVILLE, FL, July 30,
2025 &mdash; Duos Technologies Group, Inc. (&ldquo;Duos&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: DUOT) a provider of adaptive, versatile
and streamlined Edge Data Center (&ldquo;EDC&rdquo;) solutions tailored to meet evolving needs in any environment, today announced the
pricing of its upsized and oversubscribed underwritten public offering of 6,666,667 shares of its common stock at a public offering price
of $6.00 per share, before deducting underwriting discounts, commissions, and offering expenses. In addition, the Company has granted
the underwriters a 30-day option to purchase up to an additional 838,851 shares to cover over-allotments at the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">With over $40 million in
cash now expected on the balance sheet, Duos is now fully capitalized to fulfill its $50 million revenue pipeline and advance deployment
of 65 additional Edge Data Centers. The offering included primary participation from fundamental institutional investors, including a
leading long-only mutual fund, several preeminent global investment managers, and existing investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The net proceeds from the
offering will be used to expand, accelerate, and further commercialize the Company&rsquo;s Edge Data Center business. With this funding,
the Company is now fully capitalized to execute on its $50 million revenue pipeline and advance to Stage 2 of its EDC strategy, which
is the development and deployment of 65 edge data centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Titan Partners Group, a division
of American Capital Partners, is acting as the sole bookrunner for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&ldquo;We are excited to
announce this offering and the strong support from both new and existing investors,&rdquo; said Charles Ferry, CEO of the Company. &ldquo;Their
commitment reflects confidence in Duos&rsquo; future and the transformational growth we are now positioned to unlock, with a strong cash
position and accelerating demand from our Edge Data Center customers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The offering is expected
to close on or about August 1, 2025, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The offering is being made
pursuant to a shelf registration statement on Form S-3 (File No. 333-272603) filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;)
on June 12, 2023, and declared effective by the SEC on June 21, 2023 and a registration statement on Form S-3 filed pursuant to Rule 462(b)
of the Securities Act of 1933, as amended, was filed with the SEC and became effective on July 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">A preliminary prospectus
supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC&rsquo;s website
at www.sec.gov. A final prospectus supplement will be filed with the SEC. Copies of the final prospectus supplement and accompanying prospectus
relating to the offering, when available, may also be obtained by contacting Titan Partners Group LLC, a division of American Capital
Partners, LLC, 4 World Trade Center, 29th Floor, New York, NY 10007, by phone at (929) 833-1246 or by email at prospectus@titanpartnersgrp.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">This press release shall
not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in
any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 2pt 0 0">About Duos Technologies Group, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Duos Technologies Group, Inc. (Nasdaq: DUOT), based
in Jacksonville, Florida, through its wholly owned subsidiaries, Duos Technologies, Inc., Duos Edge AI, Inc., and Duos Energy Corporation,
designs, develops, deploys and operates intelligent technology solutions for Machine Vision and Artificial Intelligence (&ldquo;AI&rdquo;)
applications including real-time analysis of fast-moving vehicles, Edge Data Centers and power consulting. For more information, visit
www.duostech.com , www.duosedge.ai and www.duosenergycorp.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I>Forward- Looking Statements</I></B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><I>This news release includes forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, regarding, among other things our plans, strategies and prospects -- both business and financial. Although we believe that our
plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you
that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties
and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking
words such as &quot;believe,&quot; &quot;expect,&quot; &quot;anticipate,&quot; &quot;should,&quot; &quot;planned,&quot; &quot;will,&quot;
&quot;may,&quot; &quot;intend,&quot; &quot;estimated,&quot; and &quot;potential,&quot; among others. Any statements other than statements
of historical fact contained herein, including statements as to the completion of the offering, the satisfaction of customary closing
conditions related to the offering and the intended use of net proceeds from the offering, are forward-looking statements. Important factors
that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions
and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission.
We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements
to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except
as required by law. All forward-looking statements attributable to Duos Technologies Group, Inc. or a person acting on its behalf are
expressly qualified in their entirety by this cautionary language.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A"><B>Contacts </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A"><B>Corporate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A">Fei Kwong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #26282A">Director, Corporate Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #26282A">Duos Technologies Group, Inc. (Nasdaq: DUOT)<BR>
904-652-1625<B><BR>
</B></FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">fk@duostech.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#EAN  M /<         ,P  9@  F0  S   _P S   S,P S9@ SF0 S
MS  S_P!F  !F,P!F9@!FF0!FS !F_P"9  "9,P"99@"9F0"9S "9_P#,  #,
M,P#,9@#,F0#,S #,_P#_  #_,P#_9@#_F0#_S #__S,  #, ,S, 9C, F3,
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MS)F9_YG, )G,,YG,9IG,F9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P
M,\P 9LP F<P S,P _\PS ,PS,\PS9LPSF<PSS,PS_\QF ,QF,\QF9LQFF<QF
MS,QF_\R9 ,R9,\R99LR9F<R9S,R9_\S, ,S,,\S,9LS,F<S,S,S,_\S_ ,S_
M,\S_9LS_F<S_S,S___\  /\ ,_\ 9O\ F?\ S/\ __\S /\S,_\S9O\SF?\S
MS/\S__]F /]F,_]F9O]FF?]FS/]F__^9 /^9,_^99O^9F?^9S/^9___, /_,
M,__,9O_,F?_,S/_,____ /__,___9O__F?__S/___P   ! 0$" @(# P,$!
M0%!04&!@8'!P<(" @)"0D*"@H+"PL,# P-#0T.#@X/#P\/___P
M
M                     "'_"TU33T9&24-%.2XP%P    MM<T]035-/1D9)
M0T4Y+C!"/*3U "'_"TU33T9&24-%.2XP&     QC;5!02D-M<# W,3(    #
M2 !SO  L     +@ +0  "/\ KUF[1O#:K((($RHTB'#@PH<0$YZ+2+%B1'08
M,VK<R+&CQX\:)RZ,5I!DR8(.+18\^)"ERI<01<*<^? <R)LX<Z*CR9-ASY]
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96(AT<HH)48JJ.!BHR!6T!1RK&(MK$1  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !3 ,\# 2(  A$! Q$!_\0
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M<&M6?.-V,7MP , 2MQ^)KU#X16EO<Z/J!GMXI2+@ %T#8^4>M>7WG_']<?\
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MP/X$5@/H>G.Y8VB GLI('Y5?HIJG!;(EUZLMY/[RUINIW>D626EA,8;="2J
M XR<GK3=2OIM8A$6I>7<H.GF1+D?0XR*KT4O90O?E0_K%:UN=_>S/_L'3?\
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)[LNBE75EW/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>duot-20250730.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aAps7xRiXgen8uEYHMsSaqFmbPtx517yZkhvmhybXlqLywqFxgTVSICamTm4WUO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:DUOT="http://duostech.com/20250730" elementFormDefault="qualified" targetNamespace="http://duostech.com/20250730">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://duostech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="duot-20250730_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="duot-20250730_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>duot-20250730_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>duot-20250730_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="duot-20250730.xsd#Cover" roleURI="http://duostech.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://duostech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 30,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Duos Technologies Group, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0493217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7660 Centurion Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jacksonville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(904)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">296-2807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (par value $0.001 per share)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DUOT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="duot_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://duostech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>duot-20250730.xsd</File>
    <File>duot-20250730_lab.xml</File>
    <File>duot-20250730_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="duot_8k.htm">duot_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "duot_8k.htm": {
   "nsprefix": "DUOT",
   "nsuri": "http://duostech.com/20250730",
   "dts": {
    "schema": {
     "local": [
      "duot-20250730.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "duot-20250730_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "duot-20250730_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "duot_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://duostech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "duot_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "duot_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001079973-25-001213-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001079973-25-001213-xbrl.zip
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MK<IV5"L9B(ZP9P#3.]H\J3RPD8#<+ZF4'@@EPB+$)5;]O/(*9*ECJ>F/*V&
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M9>[8Q7ZS8BF0?<JJ<@5!AT7%@442! JP+YV&&X8J*2JU/K)3M<Q:FJ.5NP+
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MIO6W*6W:@!#J- B^/UG'R%0Q6#'E+64,GXFEUIIU/"6NJ=PGCC$LFKEC:DE
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M_:&ED=865+;HK"V(^G4AD.ZK+'MF!^M4^"I^_[[?]'GW+UJ]#Y]>MA5D81]
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M;M49,]3E!'5D.>%X- &$_JM2+S0(I$H3TFR!8-\CYQ4TMS*():23C)E@/BO
M&21N#"D&%A6X*I!++']C40++=64U<LC,^>UVE=?5E18U)(5?U'EI-U_)!3.,
M,94997'4!$K[W 2DJKA8Z!F0D%E-,+_D2!#F[YZ%#8+2<@57YK 7H2-5RN00
M!30FNDF1H3FEX4:M'&S<\B_[V052J53RVHY6+U5 P@HU4G,=9:J;Q-1Y^R07
M\&#/C*^@C"^S 'VW42[5 7H('+]R!E6(;P*X'A!,L3R+$:BXDI[CF HQ"Y62
M<00S.;X!#@X= 3%?ND23[Q *.54UF_G<QB-O /Y%RL%.-,Q,8)A7\YW=V<ZY
MYRR?>5;CIR+)G6%4AS$_B+Q(!LM#/+Y9SXQ8-VV91'B!_&.C@6=]\<W/?*6D
MLDJ+?&BROALL6SC=<5.H!#EEYLX.0H:VS/!4-[#@U4I%8^$?<](P'<24,4L2
M,WWWF#MFS(I%"[2S&PY= -Z=="TF@G=R,F=G+= SP:\ID,$-B"/5I\'2%G5@
MBSG;DB/^:JE 0U#"VQCV@_ L>!HCZC:DFXEYH'2'U%7LJH2O9A3 9> 2F= E
M"B3Z.J,ZGP@YA$#"_%A8S]7K^-\.";Z$!LB.S2 AHI%83 74="E+J)R">_]5
MA[ _C_HY8N(=LYCT#2Y5.^4'0GT6_V0A<\<(-,HV9 &J@@(BCD@ $%=*>8-.
MB>VHR 5\@9XADD+ \9Q U5A0X5.0]VYE-[=;*Z?Q1OK"'F5BVG45SD3V7L8+
M"7E1QJ8NT' \H0MU$6=K3(6:2D49@MB:JU2J*<072 :CA!>W#W7C*0"&]W?8
MA F=2U5M\M&(&=Q/HT@MIEL:ML0 O8^9!%^4E$HNBDHC>-ESP7K0!JP0. ;M
M4/L[!2VB?3^0S2X5P(^1#*'-[0E2M,&D+GC/G[8]D9_"#),8I@M*(#,JU8B&
M<@N" H0+"$Z0402#_"+AH7^TF0M%%6;E66!09'K+6@S(FR-!M8(*1A8/KD)%
M])JA \0/E#"!E!"3TQXW5;Q?Q]1N0_7U1J,UMD4#6[F.TKGCGS$OFIA?J42,
M>V;4:"XXZ5'S&P;6J?0&'W[U %_XWB$ XP+#(X=Z8IKIH>J#+V8*';#OF::B
M<QEY4$M@)81FL$Q%#M [W'=*O_9#"E2!D:$XR!WR'M;7Y4)9 2/5 B1M,#W'
M+]C,:<XG URTY0F!2(/WJ\,2#._AA:SQV;LAP-T0V  .HRR]2V.JO]F63#:
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M%I21S\8CO67\=+(]YFO4:Q0DT;X^(*A1=:/O):<$-R\V84/)KQQ5]OZGS-!
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MJ\D=5 :IZ&EUFVSA56^(G\NTOH%-#,=P=;3YG;G-]D@"?/O5)@&^/20!#DF
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M1<&61B"XN58089J:^Q:L"F9C]['/RA?I*HLY9KGD650WI&M3: 43Q4D="6!
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MA9.?>B*SA],^>-J7R^"T/Q<(W9.JKM>P*!>4C\.\KI/KKTR=OB<&Z/9%W*,
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M# J-J@J$QNOGYT]^(X,R&;8GR;H#:<!0+BG&V,^"+$U)#-\:OAC^&ER0 1@
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M:)!,[,4["5-*^^"HL)O3;YO )G/7?4LU'U7P%:1MM&RVP98)G<PT-\F6F*4
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M. @NBO9J$D_%K&OE @#AJ?A(9:%+8FZ+75*I/@V[6J=A);#G_6.'38$ZRL%
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M 7QV1[ ;X+H#E<2W+9'99*Y0@;&VG?<BHTS&9&S15:"P%N6VX9*-',#HQAK
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MXVX"<V,\L#%P?E?T^ =K<<4PL80/3HXM24(P3,#A# 6/%.LRLOAZTH>&5-S
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M'4%)M"38B$K[&*,IXO8<3IT@O034+D#8:\1/(4?.KN%H8.XYK&A8Y9-/(._
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MOP)T@U$137'0#U'Q*1;4'\/R-9&J#8CKI]N$W E.Z)_+N&3J*U]D,1+$"H8
MGDR#XU:)D^#7,F.WPU/BQW#+\?"O77H@*P=T*6*@^A7#:B?-\_DX+LZ"@\UC
MX&/CJ/2WMQ==,6?YY25PL$BQNP"Y7;=CL3L@%3^^W'IF.&+@,41@(4!,6;9"
M@!^-=O]S!]>&O_P#UXS\KAFP%WFZ!*!=QBB.XCY +H[.! &ZG39HT]4@OK\&
MB+WU *@(12;1. 5TVYBT8HFPZ:S;J<&;CESVTS %7%$8DS91:O1PAL<;34>I
MCTV0X3C)/@5'"_A&L %W& 4ER%!I!*B:%V= ;?_%[!V_.HNSR15"9!+SQN'
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M&,@6JWQ!^WMXZ[=.[2D>&Y_4O1%MY)E)6<+M;"#9> M/0?D#LC2L0 PJ;6T
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MX<9VSPG;0M!L)/ E26M+%'M)/3"/E&1 +D#]P[ R,JMB3 NRZ&%<52EKI\>
M5L#(-]HB9*<]7 &'9/?L\$]E*$+57P=S [_&<RJ!*X<6/Q=^+:?$BXG.0/=%
M ZT7K*LE.@E"+A?QA+UL APC;#8="!RE$TI QORH/ =P2J ]P.4\!B8Z+:++
MC#2RR'.48K1!L,Q2M&R0G07>IS_T1A=%#E(Q!E(XRS-@ R%X' .HT.:VU@ZZ
M';6%3?@0GOST)(?[!XB>-FU3"T J*"4$X5K!&1$?E'/X%1=SMHSPJL8LW$L$
M#S!I',]\!U^!=!X5(MGV*.X.!VJ"L9D6%UNA@<F*E[I"/#X3G%&"'<6X1L55
M UI(Y(T.]X$W5%P*JJDE6;EJD=]N]!4<5P67UAH;*)BF9%,6CIU0+XE0!PT)
M;CN=A783:-^">A3&0*=O;/(6Z"QG2S3')SK4"69JV-YZZZ= I2A#>81)VZ4B
M!P6>W/.>B1"ENRV;X2MHJ]2S-I1)2G4!&<:VR$RF((HTDJ=E FN] *ME2AH,
M4G8!;,EH$I!RPU8F'+;*T;QDJ-(:(&=8Z7#R>#:+V?,#EPA(E% <.S"O-GRW
M(^/+ZKP9*&PZB.8YH$K@9 M8][%US1J5.&U!3E@ABCI%VD6W@S%A9!($-0CD
M=PPQ,U3S^BGTL(K DGZN8<XK<*94)\O&;\K82-"N(N;P!FP0]&IB+:2N3N)D
M4>FY,QI@$Y.7O-V35D=90S$@_UCK=)DR-R2 (SJ% )07D(C2>'K&S#U"^V?
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M$I 2>"4J.2ZE4Z("A3.2?H@VV:DJ#J&FX+"!;\;W]?='Z_OZ^W??U^/U?3V
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MK >-QGV=CU(G:E@AH';S]AI="[Z3M1L7Y?KZ9,UW&;2U\RV42\%-E2,ZIKI
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MZ181=E(E*1723Q8"&B390DZ&8;W'G=,*4N?Y6AF+NE 8=MIFLU#\B>@T?8"
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MHS)/VPF8_,,*C3\C2GD+&-,H^S2Z"RJRN4IE5 '#9F!C<;%>RV;***II@*N
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M?P%02P$"% ,4    " #,@P%;YT%(!"@#  #B"P  $0              @ $
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M>#$N:'1M4$L! A0#%     @ S(,!6\??T(=&"P  %2<   D
M ( !KQX! &5X-7@Q+FAT;5!+ 0(4 Q0    ( ,R# 5MT"U#/GPL  ,0E   *
M              "  1PJ 0!E>#DY>#$N:'1M4$L! A0#%     @ S(,!6](P
M8QPZ#0  2R\   H              ( !XS4! &5X.3EX,BYH=&U02P4&
/  D "0 3 @  14,!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>duot_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="duot-20250730.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396536</identifier>
        </entity>
        <period>
            <startDate>2025-07-30</startDate>
            <endDate>2025-07-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-30" id="Fact000004">0001396536</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-30" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-30" id="Fact000010">2025-07-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-30" id="Fact000011">Duos Technologies Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-30" id="Fact000012">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-07-30" id="Fact000013">001-39227</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-30" id="Fact000014">65-0493217</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-30" id="Fact000015">7660 Centurion Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-07-30" id="Fact000016">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-30" id="Fact000017">Jacksonville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-07-30" id="Fact000018">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-30" id="Fact000019">32256</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-30" id="Fact000020">(904)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-30" id="Fact000021">296-2807</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-30" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-30" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-30" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-30" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-07-30" id="Fact000026">Common Stock (par value $0.001 per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-07-30" id="Fact000027">DUOT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-07-30" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-30" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
